MEWIGEN gene list
Please find our complete genetic analysis service list below
Gene list
Search by:
Disease | Acronym | Disease-OMIM | Gene | Gene Synonym | Gene-OMIM | Method | Filter 1 A-Z | Filter 2 Group |
---|---|---|---|---|---|---|---|---|
ABCD syndrome | ABCDS, albinism, black lock, cell migration disorder of the neurocytes of the gut, and deafness | 600501 | EDNRB | 131244 | SEQ, MLPA, NGS | A | Syndro | |
Abetalipoproteinemia | Acanthocytosis, Bassen-Kornzweig-syndrome | 200100 | MTTP | MTP | 157147 | SEQ, NGS | A | Neuro |
Achondrogenesis type 2 | ACG2 | 200610 | COL2A1 | 120140 | SEQ, MLPA, NGS | A | Tissue | |
Achondroplasia | ACH | 100800 | FGFR3 | 134934 | SEQ, MLPA, NGS | A | Tissue | |
Acro-dermato-ungual-lacrimal-tooth syndrome | ADULT syndrome | 103285 | TP63 | p63, TP73L | 603273 | SEQ, NGS | A | Syndro |
Acrodysostosis type 1, with or without hormone resistance | ACRDYS1 | 101800 | PRKAR1A | 188830 | SEQ, MLPA, NGS | A | Tissue | |
Acrodysostosis type 2, with or without hormone resistance | ACRDYS2 | 614613 | PDE4D | 600129 | SEQ, NGS | A | Tissue | |
Acromesomelic dysplasia, Hunter-Thompson type | AMDH | 201250 | GDF5 | 601146 | SEQ, NGS | A | Tissue | |
ACTH-independent macronodular adrenal hyperplasia | AIMAH1 | 219080 | GNAS somatic mutations | 139320 | SEQ, MLPA, NGS | A | Kidney | |
ACTH-independent macronodular adrenal hyperplasia | AIMAH1 | 219080 | GNAS somatic mutations | 139320 | SEQ, MLPA, NGS | A | Tumor | |
Adenosine triphosphate, elevated, of erythrocytes | pyruvate kinase hyperactivity | 102900 | PKLR | 609712 | SEQ, MLPA, NGS | A | Meta | |
Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency | 201910 | CYP21A2 | 613815 | SEQ, MLPA, NGS | A | Meta | ||
Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency | 3-beta-HSD deficiency, HSDB | 201810 | HSD3B2 | 613890 | SEQ, NGS | A | Meta | |
AEC syndrome, Hay-Wells syndrome | 106260 | TP63 | p63, TP73L | 603273 | SEQ, NGS | A | Syndro | |
Age-related macular degeneration 4 | ARMD4 | 610698 | CFH p.Y402H | HF | 134370 | SEQ | A | Sensory |
Age-related macular degeneration 8 | ARMD8 | 613778 | ARMS2 p.A69S | LOC387715 | 611313 | SEQ | A | Sensory |
Aicardi-Goutieres syndrome type 1 | AGS1 | 225750 | TREX1 | 606609 | SEQ, MLPA, NGS | A | Syndro | |
Aicardi-Goutieres syndrome type 5 | AGS5 | 612952 | SAMHD1 | 606754 | SEQ, MLPA, NGS | A | Syndro | |
Albinism, oculocutaneous, type 1A | OCA1A, tyrosinase-negative OCA1 | 203100 | TYR null mutation | 606933 | SEQ, MLPA, NGS | A | Meta | |
Albinism, oculocutaneous, type 1B | OCA1B, tyrosinase-positive OCA1 | 606952 | TYR hypomorphic mutation | 606933 | SEQ, MLPA, NGS | A | Meta | |
Albinism, oculocutaneous, type 2 | OCA2 | 203200 | OCA2 | P gene, pink-eyed dilution | 611409 | SEQ, MLPA, NGS | A | Meta |
Albinism, oculocutaneous, type 3 | OCA3 | 203290 | TYRP1 | 115501 | SEQ, NGS | A | Meta | |
Albinism, oculocutaneous, type 4 | OCA4 | 606574 | SLC45A2 | MATP | 606202 | SEQ, NGS | A | Meta |
Albinism, oculocutaneous, type 6 | OCA6 | 113750 | SLC24A5 | 609802 | SEQ, NGS | A | Meta | |
Albinism, oculocutaneous, type 7 | OCA7 | 615179 | C10ORF11 | 614537 | SEQ, NGS | A | Meta | |
Albright hereditary osteodystrophy, Pseudohypoparathyroidism type Ia | PHP1A | 103580 | GNAS | 139320 | SEQ, MLPA, NGS | A | Tissue | |
Alexander disease | 203450 | GFAP | 137780 | SEQ, NGS | A | Neuro | ||
Alpha-1-antitrypsin deficiency | A1ATD | 613490 | SERPINA1, exons 3 and 5 | 107400 | SEQ, MLPA | A | Meta | |
Alpha-thalassemia/mental retardation syndrome, X-linked | ATRX | 301040 | ATRX | 300032 | SEQ, MLPA, NGS | A | Syndro | |
Alport syndrome 1, X-linked | ATS1 | 301050 | COL4A5 | 303630 | SEQ, MLPA, NGS | A | Kidney | |
Alport syndrome 1, X-linked | ATS1 | 301050 | COL4A5 | 303630 | SEQ, MLPA, NGS | A | Syndro | |
Alport syndrome 2, autosomal recessive | ATS2 | 203780 | COL4A3 | 120070 | SEQ, MLPA, NGS | A | Kidney | |
Alport syndrome 2, autosomal recessive | ATS2 | 203780 | COL4A4 | 120131 | SEQ, MLPA, NGS | A | Syndro | |
Alport syndrome 3, autosomal dominant | ATS3 | 104200 | COL4A3 | 120070 | SEQ, MLPA, NGS | A | Kidney | |
Alport syndrome 3, autosomal dominant | ATS3 | 104200 | COL4A3 | 120070 | SEQ, MLPA, NGS | A | Syndro | |
Alternating hemiplegia of childhood 1 | AHC1 | 104290 | ATP1A2 | 182340 | SEQ, MLPA, NGS | A | Neuro | |
Alternating hemiplegia of childhood 2 | AHC2 | 614820 | ATP1A3 | 182350 | SEQ, MLPA, NGS | A | Neuro | |
Alzheimer disease type 1, familial | AD | 104300 | APP | 104760 | SEQ, MLPA, NGS | A | Neuro | |
Alzheimer disease type 2, familial | AD2 | 104310 | APOE E2/E3/E4-Allele | 107741 | SEQ | A | Neuro | |
Alzheimer disease type 3, familial | DAT | 607822 | PSEN1 | 104311 | SEQ, MLPA, NGS | A | Neuro | |
Alzheimer disease type 4, familial | DAT | 606889 | PSEN2 | 600759 | SEQ, MLPA, NGS | A | Neuro | |
AMP deaminase deficiency | Myoadenylat deaminase deficiency | 615511 | AMPD1 | 102770 | SEQ, NGS | A | Neuro | |
Amyloidosis, hereditary, transthyretin-related | Amyloid polyneuropathy | 105210 | TTR | 176300 | SEQ, NGS | A | Meta | |
Amyotrophic lateral sclerosis type 1 | ALS1 | 105400 | SOD1 | 147450 | SEQ, NGS | A | Neuro | |
Amyotrophic lateral sclerosis type 10 | ALS10 | 612069 | TARDBP | TDP43 | 605078 | SEQ, NGS | A | Neuro |
Amyotrophic lateral sclerosis type 11 | ALS11 | 612577 | FIG4 | 609390 | SEQ, NGS | A | Neuro | |
Amyotrophic lateral sclerosis type 14, with or without frontotemporal dementia | ALS14 | 613954 | VCP | 601023 | SEQ, NGS | A | Neuro | |
Amyotrophic lateral sclerosis type 2, juvenile | ALS2 | 205100 | ALS2 | KIAA1563 | 606352 | SEQ, NGS | A | Neuro |
Amyotrophic lateral sclerosis type 4, juvenile | ALS4 | 602433 | SETX | 608465 | SEQ, MLPA, NGS | A | Neuro | |
Amyotrophic lateral sclerosis type 6, with or without frontotemporal dementia | ALS6 | 608030 | FUS | 137070 | SEQ, NGS | A | Neuro | |
Amyotrophic lateral sclerosis type 8 | ALS8 | 608627 | VAPB | 605704 | SEQ, NGS | A | Neuro | |
Amyotrophic lateral sclerosis type 9 | ALS9 | 611895 | ANG | 105850 | SEQ, NGS | A | Neuro | |
Andersen-Tawil syndrome | ATS, LQT7, periodic paralysis + ventricular arrhythmias + distinctive dysmorphic facial or skeletal features | 170390 | KCNJ2 | 600681 | SEQ, MLPA, NGS | A | Cardio | |
Androgen insensitivity | AIS | 300068 | AR | 313700 | SEQ, MLPA, NGS | A | Meta | |
Androgen insensitivity, partial, with or without breast cancer | PAIS | 312300 | AR | 313700 | SEQ, MLPA, NGS | A | Meta | |
Angioedema, hereditary, type III | HAE3 | 610618 | F12 | 610619 | SEQ, MLPA, NGS | A | Meta | |
Angioedema, hereditary, types I and II | HAE1, HAE2 | 106100 | SERPING1 | C1NH | 606860 | SEQ, MLPA, NGS | A | Meta |
Aniridia | AN1, congenital cataract with late-onset corneal-dystrophy | 106210 | PAX6 | 607108 | SEQ, MLPA, NGS | A | Sensory | |
Anophthalmia / Microphthalmia, syndromic | SOX2-related eye disorders | 206900 | SOX2 | 184429 | SEQ, MLPA, NGS | A | Syndro | |
Anterior segment dysgenesis, type 3 | ASGD3 | 601631 | FOXC1 | 601090 | SEQ, MLPA, NGS | A | Sensory | |
Anterior segment dysgenesis, type 4 | ASGD4 | 137600 | PITX2 | 601542 | SEQ, MLPA, NGS | A | Sensory | |
Anterior segment dysgenesis, type 5 | ASGD5 | 604229 | PAX6 | 607108 | SEQ, MLPA, NGS | A | Sensory | |
Apert syndrome | Acrocephalosyndactyly type 1 | 101200 | FGFR2 | 176943 | SEQ, MLPA, NGS | A | Syndro | |
Aphasia, primary progressive | PPA | 607485 | GRN | PGRN | 138945 | SEQ, MLPA, NGS | A | Neuro |
Apolipoprotein B100, familial ligand-defective | Hypercholesterolemia, familial, 2, FCHL2 | 144010 | APOB p.R3527Q [R3500Q], p.R3558C [R3531C] | 107730 | SEQ | A | Meta | |
Argininemia | Arginase deficiency | 207800 | ARG1 | 608313 | SEQ, NGS | A | Meta | |
Argininemia | Arginase deficiency | 207800 | ARG1 | 608313 | SEQ, NGS | A | Path | |
Argininosuccinase deficiency | Argininosuccinic aciduria | 207900 | ASL | 608310 | SEQ, NGS | A | Path | |
Argininosuccinase deficiency | Argininosuccinic aciduria | 207900 | ASL | 608310 | SEQ, NGS | A | Meta | |
Aromatic L-amino acid decarboxylase deficiency | AADCD, dopa decarboxylase deficiency | 608643 | DDC | AADC | 107930 | SEQ, NGS | A | Neuro |
Arthrogryposis multiplex congenita, distal type 1 | AMCD1 | 108120 | TPM2 | 190990 | SEQ, NGS | A | Syndro | |
Arts syndrome | ARTS | 301835 | PRPS1 | 311850 | SEQ, NGS | A | Syndro | |
Association with statin-induced side effects | SLCO1B1*5 Genetic Variant | c.521T>C, p.V174A | 604843 | SEQ | A | Pharma | ||
Ataxia teleangiectasia | Louis-Bar-syndrome | 208900 | ATM | 607585 | SEQ, MLPA, NGS | A | Neuro | |
Ataxia teleangiectasia | Louis-Bar syndrome | 208900 | ATM | 607585 | SEQ, MLPA, NGS | A | Tumor | |
Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia | AOA1 | 208920 | APTX | 606350 | SEQ, MLPA, NGS | A | Neuro | |
Atrial fibrillation, familial, 4 | ATFB4 | 611493 | KCNE2 | 603796 | SEQ, MLPA, NGS | A | Cardio | |
Attenuated familial adenomatous polyposis | AFAP | 175100 | APC | 611731 | SEQ, MLPA, NGS | A | Tumor | |
Attenuated familial adenomatous polyposis | AFAP | 175100 | MUTYH | 604933 | SEQ, MLPA, NGS | A | Tumor | |
Atypical Gaucher disease due to saposin C deficiency | 610539 | PSAP | 176801 | SEQ, NGS | A | Meta | ||
Atypical Krabbe disease due to saposin A deficiency | Saposin A deficiency | 611722 | PSAP | 176801 | SEQ, NGS | A | Meta | |
Axenfeld-Rieger syndrome type 1 | RIEG1 | 180500 | PITX2 | 601542 | SEQ, MLPA, NGS | A | Sensory | |
Axenfeld-Rieger syndrome type 3 | RIEG3 | 602482 | FOXC1 | 601090 | SEQ, MLPA, NGS | A | Sensory | |
Bannayan-Riley-Ruvalcaba syndrome | BBRS | 158350 | PTEN | 601728 | SEQ, MLPA, NGS | B | Tumor | |
Basal cell nevus syndrome | BCNS, Gorlin-Goltz syndrome | 109400 | PTCH1 | 601309 | SEQ, MLPA, NGS | B | Tumor | |
Basal cell nevus syndrome | BCNS, Gorlin-Goltz syndrome | 109400 | PTCH2 | 603673 | SEQ, NGS | B | Tumor | |
Basal cell nevus syndrome | BCNS, Gorlin-Goltz syndrome | 109400 | SUFU | 607035 | SEQ, MLPA, NGS | B | Tumor | |
Basal ganglia calcification, idiopathic, 7, autosomal recessive | IBGC7 | 618317 | MYORG | 618255 | SEQ, NGS | B | Neuro | |
Basal ganglia calcification, idiopathic, type 1, Fahr disease | IBGC1 | 213600 | SLC20A2 | 158378 | SEQ, NGS | B | Neuro | |
Basal ganglia calcification, idiopathic, type 4, Fahr disease | IBGC4 | 615007 | PDGFRB | 173410 | SEQ, NGS | B | Neuro | |
Basal ganglia calcification, idiopathic, type 5, Fahr disease | IBGC5 | 615483 | PDGFB | 190040 | SEQ, NGS | B | Neuro | |
Basal ganglia calcification, idiopathic, type 6, Fahr disease | IBGC6 | 616413 | XPR1 | 605237 | SEQ, NGS | B | Neuro | |
Beare-Stevenson syndrome | BSTVS | 123790 | FGFR2 | 176943 | SEQ, MLPA, NGS | B | Syndro | |
Becker muscular dystrophy | BMD | 300376 | DMD | 300377 | SEQ, MLPA, NGS | B | Neuro | |
Beckwith-Wiedemann syndrome | BWS | 130650 | CDKN1C | KIP2 | 600856 | SEQ, MLPA, NGS | B | Syndro |
Benign familial infantile seizures, type 2 | BFIE2 | 605751 | PRRT2 | 614386 | SEQ, MLPA, NGS | B | Epi | |
Benign hereditary Chorea | BHC | 118700 | NKX2-1 | 600635 | SEQ, MLPA, NGS | B | Neuro | |
Bestrophinopathy, autosomal recessive | ARB | 611809 | BEST1 | 607854 | SEQ, MLPA, NGS | B | Sensory | |
Bietti crystalline corneoretinal dystrophy | BCD | 210370 | CYP4V2 | 608614 | SEQ, NGS | B | Sensory | |
Birt-Hogg-Dubé syndrome | BHD | 135150 | FLCN | 607273 | SEQ, MLPA, NGS | B | Neuro | |
Blepharophimosis, epicanthus inversus, and ptosis type 1 and 2 | BPES | 110100 | FOXL2 | 605597 | SEQ, MLPA, NGS | B | Syndro | |
Blood group-Lutheran inhibitor, dominant LU(a-b-) phenotype | INLU | 111150 | KLF1 | 600599 | SEQ, NGS | B | Coagul | |
Borjeson-Forssman-Lehmann syndrome | BFLS | 301900 | PHF6 | 300414 | SEQ, MLPA, NGS | B | Syndro | |
Boucher-Neuhauser-syndrome | BNHS | 215470 | PNPLA6 | 603197 | SEQ, NGS | B | Neuro | |
Brachydactyly, type A1 | Farabee brachydactyly | 112500 | IHH | 600726 | SEQ, NGS | B | Tissue | |
Brachydactyly, type C | BDC, Haws type | 113100 | GDF5 | 601146 | SEQ, NGS | B | Tissue | |
Brachydactyly, type D | BDD | 113200 | HOXD13 | 142989 | SEQ, MLPA, NGS | B | Tissue | |
Brachydactyly, type E | BDE1 | 113300 | HOXD13 | 142989 | SEQ, MLPA, NGS | B | Tissue | |
Brachydactyly, type E2 | BDE2 | 613382 | PTHLH | 168470 | SEQ, NGS | B | Tissue | |
Brachydactyly-syndactyly syndrome | Zhao type, BDSD | 610713 | HOXD13 | 142989 | SEQ, MLPA, NGS | B | Tissue | |
Brachyolmia type 3 | 113500 | TRPV4 | 605427 | SEQ, NGS | B | Tissue | ||
Breast cancer, susceptibility | 114480 | PALB2 | FANCN | 610355 | SEQ, MLPA, NGS | B | Tumor | |
Brugada syndrome type 1 | BRGDA1, Right bundle branch block, ST segment elevation, sudden death | 601144 | SCN5A | 600163 | SEQ, MLPA, NGS | B | Cardio | |
Brugada syndrome type 2 | BRGDA2 | 611777 | GPD1L | 611778 | SEQ, NGS | B | Cardio | |
Brugada syndrome type 3 | BRGDA3 | 611875 | CACNA1C | 114205 | SEQ, NGS | B | Cardio | |
Brugada syndrome type 4 | BRGDA4 | 611876 | CACNB2 | 600003 | SEQ, NGS | B | Cardio | |
Brugada syndrome type 5 | BRGDA5 | 612838 | SCN1B | 600235 | SEQ, NGS | B | Cardio | |
Brugada syndrome type 6 | BRGDA6 | 613119 | KCNE3 | 604433 | SEQ, NGS | B | Cardio | |
Brugada syndrome type 7 | BRGDA7 | 613120 | SCN3B | 608214 | SEQ, NGS | B | Cardio | |
Brugada syndrome type 8 | BRGDA8 | 613123 | HCN4 | 605206 | SEQ, NGS | B | Cardio | |
Brugada syndrome type 9 | BRGDA9 | 616399 | KCND3 | 605411 | SEQ, NGS | B | Cardio | |
Campomelic dysplasia | CMPD | 114290 | SOX9 | 608160 | SEQ, MLPA, NGS | C | Syndro | |
Campomelic dysplasia with autosomal sex reversal | CMPD | 114290 | SOX9 | 608160 | SEQ, MLPA, NGS | C | Syndro | |
Camptodactyly, tall stature and hearing loss | CATSHL syndrome | 610474 | FGFR3 mutation p.Arg621His | 134934 | SEQ | C | Syndro | |
Camurati-Engelmann disease | 131300 | TGFB1 | 190180 | SEQ, NGS | C | Tissue | ||
Carbamoylphosphate synthetase I deficiency | CPS1 deficiency | 237300 | CPS1 | 608307 | SEQ, NGS | C | Meta | |
Carbamoylphosphate synthetase I deficiency | CPS1 deficiency | 237300 | CPS1 | 608307 | SEQ, NGS | C | Path | |
Cardiofaciocutaneous syndrome 1 | CFC1 | 115150 | BRAF | 164757 | SEQ, NGS | C | Syndro | |
Cardiofaciocutaneous syndrome 2 | CFC2 | 615278 | KRAS | 190070 | SEQ, NGS | C | Syndro | |
Cardiomyopathy, dilated, 1A | CMD1A | 115200 | LMNA | 150330 | SEQ, MLPA, NGS | C | Cardio | |
Cardiomyopathy, dilated, 1D | CMD1D | 601494 | TNNT2 | 191045 | SEQ, MLPA, NGS | C | Cardio | |
Cardiomyopathy, dilated, 1E | CMD1E | 601154 | SCN5A | 600163 | SEQ, MLPA, NGS | C | Cardio | |
Cardiomyopathy, dilated, 1FF | CMD1FF | 613286 | TNNI3 | 191044 | SEQ, NGS | C | Cardio | |
Cardiomyopathy, dilated, 1MM | CMD1MM | 615396 | MYBPC3 | 600958 | SEQ, MLPA, NGS | C | Cardio | |
Cardiomyopathy, dilated, 1S | CMD1S | 613426 | MYH7 | 160760 | SEQ, MLPA, NGS | C | Cardio | |
Cardiomyopathy, dilated,1GG | CMD1GG | 613642 | SDHA | 600857 | SEQ, MLPA, NGS | C | Cardio | |
Cardiomyopathy, dilated,1U | CMD1U | 613694 | PSEN1 | 104311 | SEQ, MLPA, NGS | C | Cardio | |
Cardiomyopathy, dilated,1V | CMD1V | 613697 | PSEN2 | 600759 | SEQ, MLPA, NGS | C | Cardio | |
Cardiomyopathy, dilated,1Y | CMD1Y | 611878 | TPM1 | 191010 | SEQ, NGS | C | Cardio | |
Cardiomyopathy, familial hypertrophic | CMH | 192600 | CAV3 | 601253 | SEQ, MLPA, NGS | C | Cardio | |
Cardiomyopathy, familial hypertrophic 1 | CMH1 | 192600 | MYH7 | 160760 | SEQ, MLPA, NGS | C | Cardio | |
Cardiomyopathy, familial hypertrophic 10 | CMH10 | 608758 | MYL2 | 160781 | SEQ, NGS | C | Cardio | |
Cardiomyopathy, familial hypertrophic 2 | CMH2 | 115195 | TNNT2 | 191045 | SEQ, MLPA, NGS | C | Cardio | |
Cardiomyopathy, familial hypertrophic 3 | CMH3 | 115196 | TPM1 | 191010 | SEQ, NGS | C | Cardio | |
Cardiomyopathy, familial hypertrophic 4 | CMH4 | 115197 | MYBPC3 | 600958 | SEQ, MLPA, NGS | C | Cardio | |
Cardiomyopathy, familial hypertrophic 7 | CMH7 | 613690 | TNNI3 | 191044 | SEQ, NGS | C | Cardio | |
Cardiomyopathy, familial hypertrophic 8 | CMH8 | 608751 | MYL3 | 160790 | SEQ, NGS | C | Cardio | |
Carney complex, type 1 | CNC1 | 160980 | PRKAR1A | 188830 | SEQ, MLPA, NGS | C | Tumor | |
Catecholaminergic polymorphic ventricular tachycardia-3 | CPVT3 | 614021 | TECRL | 617242 | SEQ, NGS | C | Cardio | |
Catecholaminergic polymorphic ventricular tachycardia-6 | CPVT6 | 618782 | CALM3 | 114183 | SEQ, NGS | C | Cardio | |
Celiac disease, susceptibility | 212750 | HLA-DQA1 and-DQB1, analysis of risk-alleles encoding HLA-DQ2 and -DQ8 only | 146880, 604305 | SEQ | C | Meta | ||
Cerebellar ataxia, areflexia, pes cavus, optic atrophy and sensorineural hearing loss | CAPOS-syndrome | 601338 | ATP1A3 | 182350 | SEQ, MLPA, NGS | C | Neuro | |
Cerebellar ataxia, mental retardation and dysequilibrium syndrome 1 | CAMRQ1 | 224050 | VLDLR | 192977 | SEQ, MLPA, NGS | C | Neuro | |
Cerebeller ataxia, mental retardation and dysequilibrium syndrome 3 | CAMRQ3 | 613227 | CA8 | 114815 | SEQ, NGS | C | Neuro | |
Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 | CADASIL1 | 125310 | NOTCH3 | 600276 | SEQ, MLPA, NGS | C | Neuro | |
cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 | CADASIL2 | 616779 | HTRA1 | 602194 | SEQ, NGS | C | Neuro | |
cerebral arteriopathy, autosomal recessive, with subcortical infarcts and leukoencephalopathy | CARASIL , Maeda syndrome | 600142 | HTRA1 | 602194 | SEQ, NGS | C | Neuro | |
Cerebrooculofacioskeletal syndrome type 1 | COFS1, Pena-Shokeir syndrome type 2 | 214150 | ERCC6 | 609413 | SEQ, NGS | C | Syndro | |
Cerebrooculofacioskeletal syndrome type 2 | COFS2 | 610756 | ERCC2 | 126340 | SEQ, NGS | C | Syndro | |
Cerebrooculofacioskeletal syndrome type 3 | COFS3 | 616570 | ERCC5 | 133530 | SEQ, NGS | C | Syndro | |
Ceroid lipofuscinosis, neuronal, 2 | CLN2, Jansky-Bielschowsky disease, late infantile form included | 204500 | TPP1 | 607998 | SEQ, MLPA, NGS | C | Meta | |
Ceroid lipofuscinosis, neuronal, 4a, autosomal recessive | CLN4A, adult onset, Kufs type | 204300 | CLN6 | 606725 | SEQ, MLPA, NGS | C | Meta | |
Ceroid lipofuscinosis, neuronal, 6 | CLN6, late infantile, variant | 601780 | CLN6 | 606725 | SEQ, MLPA, NGS | C | Meta | |
Ceroid-Lipofuscinose, neuronal, Typ 1 | CLN1, infantile Santavuori-Haltia disease included | 256730 | PPT1 | 600722 | SEQ, MLPA, NGS | C | Meta | |
Charcot-Marie-Tooth neuropathy type 1A | CMT1A, HMSN1A | 118220 | PMP22 | 601097 | SEQ, MLPA, NGS | C | Neuro | |
Charcot-Marie-Tooth neuropathy type 1B | CMT1B, HMSN1B | 118200 | MPZ | P0 | 159440 | SEQ, MLPA, NGS | C | Neuro |
Charcot-Marie-Tooth neuropathy type 1C | CMT1C, HMSN1C | 601098 | LITAF | 603795 | SEQ, NGS | C | Neuro | |
Charcot-Marie-Tooth neuropathy type 1D | CMT1D, HMSN1D | 607678 | EGR2 | 129010 | SEQ, MLPA, NGS | C | Neuro | |
Charcot-Marie-Tooth neuropathy type 1E | CMT1E, HMSN1E | 118300 | PMP22 | 601097 | SEQ, MLPA, NGS | C | Neuro | |
Charcot-Marie-Tooth neuropathy type 1F | CMT1F, HMSN1F | 607734 | NEFL | NF68 | 162280 | SEQ, MLPA, NGS | C | Neuro |
Charcot-Marie-Tooth neuropathy type 2A2 | CMT2A2, HMSN2A2 | 609260 | MFN2 | 608507 | SEQ, MLPA, NGS | C | Neuro | |
Charcot-Marie-Tooth neuropathy type 2B | CMT2B, HMSN2B | 600882 | RAB7A | 602298 | SEQ, MLPA, NGS | C | Neuro | |
Charcot-Marie-Tooth neuropathy type 2B1 | CMT2B1, HMSN2B1 | 605588 | LMNA | 150330 | SEQ, MLPA, NGS | C | Neuro | |
Charcot-Marie-Tooth neuropathy type 2C | CMT2C, HMSN2C | 606071 | TRPV4 | 605427 | SEQ, NGS | C | Neuro | |
Charcot-Marie-Tooth neuropathy type 2D | CMT2D, HMSN2D | 601472 | GARS1 | GARS | 600287 | SEQ, MLPA, NGS | C | Neuro |
Charcot-Marie-Tooth neuropathy type 2E | CMT2E, HMSN2E | 607684 | NEFL | NF68 | 162280 | SEQ, MLPA, NGS | C | Neuro |
Charcot-Marie-Tooth neuropathy type 2I | CMT2I, HMSN2I | 607677 | MPZ | P0 | 159440 | SEQ, MLPA, NGS | C | Neuro |
Charcot-Marie-Tooth neuropathy type 2J | CMT2J, HMSN2J | 607736 | MPZ | P0 | 159440 | SEQ, MLPA, NGS | C | Neuro |
Charcot-Marie-Tooth neuropathy type 2Y | CMT2Y | 616687 | VCP | 601023 | SEQ, NGS | C | Neuro | |
Charcot-Marie-Tooth neuropathy type 4A | CMT4A | 214400 | GDAP1 | 606598 | SEQ, MLPA, NGS | C | Neuro | |
Charcot-Marie-Tooth neuropathy type 4B1 | CMT4B1 | 601382 | MTMR2 | 603557 | SEQ, MLPA, NGS | C | Neuro | |
Charcot-Marie-Tooth neuropathy type 4J | CMT4J | 611228 | FIG4 | 609390 | SEQ, NGS | C | Neuro | |
Charcot-Marie-Tooth neuropathy type X | CMTX, HMSNX | 302800 | GJB1 | Connexin 32 | 304040 | SEQ, MLPA, NGS | C | Neuro |
Charcot-Marie-Tooth neuropathy type X5 | Rosenberg-Chutorian-syndrome, CMTX5 | 311070 | PRPS1 | 311850 | SEQ, NGS | C | Neuro | |
Charcot-Marie-Tooth neuropathy, axonal, type 2F | CMT2F | 606595 | HSPB1 | 602195 | SEQ, MLPA, NGS | C | Neuro | |
Charcot-Marie-Tooth neuropathy, axonal, type 2K | CMT2K | 607831 | GDAP1 | 606598 | SEQ, MLPA, NGS | C | Neuro | |
Charcot-Marie-Tooth neuropathy, axonal, type 2L | CMT2L | 608673 | HSPB8 | 608014 | SEQ, MLPA, NGS | C | Neuro | |
Charcot-Marie-Tooth neuropathy, axonal, type 2M | CMT2M | 606482 | DNM2 | 602378 | SEQ, NGS | C | Neuro | |
Charcot-Marie-Tooth neuropathy, axonal, type 2N | CMT2N | 613287 | AARS | 601065 | SEQ, NGS | C | Neuro | |
Charcot-Marie-Tooth neuropathy, axonal, with vocal cord paresis | 607706 | GDAP1 | 606598 | SEQ, MLPA, NGS | C | Neuro | ||
Charcot-Marie-Tooth neuropathy, dominant intermediate, type B | CMTDIB | 606482 | DNM2 | 602378 | SEQ, NGS | C | Neuro | |
Chediak-Higashi syndrome | CHS | 214500 | LYST | CHS1 | 606897 | SEQ, NGS | C | Syndro |
Cherubism | CRBM | 118400 | SH3BP2 | 602104 | SEQ, NGS | C | Syndro | |
Chilblain lupus type 1 | CHBL1 | 610448 | TREX1 | 606609 | SEQ, MLPA, NGS | C | Geno | |
Chilblain lupus type 2 | CHBL2 | 614415 | SAMHD1 | 606754 | SEQ, MLPA, NGS | C | Geno | |
Cholelithiasis, low phospholipid-associated | LPAC, Gallbladder disease 1 | 600803 | ABCB4 | 171060 | SEQ, MLPA, NGS | C | Meta | |
Cholestasis, benign recurrent intrahepatic, type 1 | BRIC1, Summerskill syndrome | 243300 | ATP8B1 | 602397 | SEQ, NGS | C | Meta | |
Cholestasis, benign recurrent intrahepatic, type 2 | BRIC2 | 605479 | ABCB11 | 603201 | SEQ, NGS | C | Meta | |
Cholestasis, intrahepatic, of pregnancy, 1 | ICP1 | 147480 | ATP8B1 | 602397 | SEQ, NGS | C | Meta | |
Cholestasis, intrahepatic, of pregnancy, 3 | ICP3 | 614972 | ABCB4 | 171060 | SEQ, MLPA, NGS | C | Meta | |
Cholestasis, progressive familial intrahepatic, type 1 | PFIC1, Byler Disease | 211600 | ATP8B1 | 602397 | SEQ, NGS | C | Meta | |
Cholestasis, progressive familial intrahepatic, type 2 | PFIC2 | 601847 | ABCB11 | 603201 | SEQ, NGS | C | Meta | |
Cholestasis, progressive familial intrahepatic, type 3 | PFIC3 | 602347 | ABCB4 | 171060 | SEQ, MLPA, NGS | C | Meta | |
Chondrodysplasia, Blomstrand type | 215045 | PTH1R | 168468 | SEQ, NGS | C | Tissue | ||
Chondrodysplasia, Grebe type | 200700 | GDF5 | 601146 | SEQ, NGS | C | Tissue | ||
Choreoacanthocytosis | Neuroacanthocytosis, Levine-Critchley syndrome | 200150 | VPS13A | 605978 | SEQ, NGS | C | Neuro | |
Choreoathetosis and congenital hypothyroidism with or without pulmonary dysfunction | CAHTP, brain-lung-thyroid syndrome | 610978 | NKX2-1 | 600635 | SEQ, MLPA, NGS | C | Neuro | |
Choroidal dystrophy, central areolar, type 2 | CACD | 613105 | PRPH2 | 179605 | SEQ, MLPA, NGS | C | Sensory | |
Chronic progressive external ophthalmoplegia type 2 | CPEO2, PEOA2 progressive external ophthalmoplegia 2 | 609283 | SLC25A4 | ANT1 | 103220 | SEQ, MLPA, NGS | C | Neuro |
Chronic progressive external ophthalmoplegia type 3, | CPEO3, progressive external ophthalmoplegia 3, PEOA3 | 609286 | TWNK | C10ORF2, TWINKLE | 606075 | SEQ, MLPA, NGS | C | Neuro |
Chronic progressive external ophthalmoplegia type 4 | CPEO4, PEOA4 progressive external ophthalmoplegia 4 | 610131 | POLG2 | 604983 | SEQ, MLPA, NGS | C | Neuro | |
Chronic progressive external ophthalmoplegia type 5 | CPEO5, PEOA5 progressive external ophthalmoplegia 5 | 613077 | RRM2B | 604712 | SEQ, MLPA, NGS | C | Neuro | |
Citrullinemia, classic | Citrullinemia type I, CTLN1 | 215700 | ASS1 | 603470 | SEQ, NGS | C | Meta | |
Citrullinemia, classic | Citrullinemia type I, CTLN1 | 215700 | ASS1 | 603470 | SEQ, NGS | C | Path | |
Citrullinemia, type II, adult-onset | CTLN2, Citrin deficiency | 603471 | SLC25A13 | 603859 | SEQ, NGS | C | Meta | |
Citrullinemia, type II, adult-onset | CTLN2, citrin deficiency | 603471 | SLC25A13 | 603859 | SEQ, NGS | C | Path | |
Citrullinemia, type II, neonatal-onset | Cholestasis, neonatal intrahepatic, caused by citrin deficiency, NICCD | 605814 | SLC25A13 | 603859 | SEQ, NGS | C | Meta | |
Citrullinemia, type II, neonatal-onset | Neonatal intrahepatic cholestasis caused by citrin deficiency, NICCD | 605814 | SLC25A13 | 603859 | SEQ, NGS | C | Path | |
Cleidocranial dysplasia | CCD | 119600 | RUNX2 | 600211 | SEQ, MLPA, NGS | C | Tissue | |
Cockayne syndrome, type A | CSA | 216400 | ERCC8 | 609412 | SEQ, NGS | C | Syndro | |
Cockayne syndrome, type B | CSB | 133540 | ERCC6 | 609413 | SEQ, NGS | C | Syndro | |
Coffin-Lowry syndrome | 303600 | RPS6KA3 | 300075 | SEQ, MLPA, NGS | C | Syndro | ||
Cohen syndrome | COH1 | 216550 | VPS13B | 607817 | SEQ, MLPA, NGS | C | Syndro | |
Colorectal Cancer, susceptibility type 10 | 612591 | POLD1 | 174761 | SEQ, NGS | C | Tumor | ||
Colorectal Cancer, susceptibility type 12 | 615083 | POLE | 174762 | SEQ, NGS | C | Tumor | ||
Combined saposin deficiency | 611721 | PSAP | 176801 | SEQ, NGS | C | Neuro | ||
Complex cortical dysplasia with other brain malformations type 1 | CDCBM1 | 614039 | TUBB3 | 602661 | SEQ, NGS | C | Neuro | |
Congenital bilateral absence of vas deferens | CBAVD | 277180 | CFTR | 602421 | SEQ, MLPA, NGS | C | Syndro | |
Congenital fibrosis of extraocular muscles type 1 | CFEOM1 | 135700 | KIF21A | 608283 | SEQ, NGS | C | Sensory | |
Congenital fibrosis of extraocular muscles type 2 | CFEOM2 | 602078 | PHOX2A | ARIX | 602753 | SEQ, NGS | C | Sensory |
Congenital fibrosis of extraocular muscles type 3A | CFEOM3A | 600638 | TUBB3 | 602661 | SEQ, NGS | C | Sensory | |
Congenital fibrosis of extraocular muscles type 3B | CFEOM3B | 135700 | KIF21A | 608283 | SEQ, NGS | C | Sensory | |
Congenital heart defects, multiple types, 5 | 617912 | GATA5 | 611496 | SEQ, NGS | C | Tissue | ||
Congenital nongoitrous hypothyroidism-1 | CHNG1 | 275200 | TSHR | 603372 | SEQ, MLPA, NGS | C | Meta | |
Contractural arachnodactyly, congenital | CCA, Beals syndrome, Beals-Hecht syndrome | 121050 | FBN2 exons 8, 9, 17, 24 – 35 | 612570 | SEQ | C | Tissue | |
Cornelia de Lange syndrome 1 | CDLS1 | 122470 | NIPBL | 608667 | SEQ, MLPA, NGS | C | Syndro | |
Coronary artery disease, autosomal dominant, 2 | ADCAD2 | 610947 | LRP6 | 603507 | SEQ, NGS | C | Cardio | |
Corpus callosum, agenesis of, with abnormal genitalia | Proud syndrome | 300004 | ARX | 300382 | SEQ, MLPA, NGS | C | Syndro | |
Costello syndrome | Faciocutaneoskeletal (FCS) syndrome | 218040 | HRAS | 190020 | SEQ, NGS | C | Syndro | |
Cowden syndrome, type 1 | 158350 | PTEN | 601728 | SEQ, MLPA, NGS | C | Tumor | ||
Cowden syndrome, type 2 | 612359 | SDHB | 185470 | SEQ, MLPA, NGS | C | Tumor | ||
Cowden syndrome, type 3 | 615106 | SDHD | 602690 | SEQ, MLPA, NGS | C | Tumor | ||
Cowden syndrome, type 5 | 615108 | PIK3CA | 171834 | SEQ, NGS | C | Tumor | ||
Craniosynostosis type 1 | CRS1 | 123100 | TWIST1 | 601622 | SEQ, MLPA, NGS | C | Syndro | |
CRASH syndrome | Corpus callosum hypoplasia, retardation, adducted thumbs, spastic paraplegia, and hydrocephalus | 303350 | L1CAM | 308840 | SEQ, MLPA, NGS | C | Syndro | |
Creatine phosphokinase, elevated serum | high serum CPK | 123320 | CAV3 | 601253 | SEQ, MLPA, NGS | C | Cardio | |
Creutzfeld-Jakob disease | familial, CJD | 123400 | PRNP | 176640 | SEQ, NGS | C | Neuro | |
Crigler-Najjar syndrome type I | Hyperbilirubinemia, Crigler-Najjar type I (HBLRCN1) | 218800 | UGT1A1 | UGT1 | 191740 | SEQ, NGS | C | Meta |
Crigler-Najjar syndrome type II | Hyperbilirubinemia, Crigler-Najjar type II (HBLRCN2) | 606785 | UGT1A1 | UGT1 | 191740 | SEQ, NGS | C | Meta |
Crouzon syndrome | Craniofacial dysostosis, type 1, CFD1 | 123500 | FGFR2 | 176943 | SEQ, MLPA, NGS | C | Syndro | |
Crouzon syndrome with acanthosis nigricans | CAN | 612247 | FGFR3 mutation p.Ala391Glu | 134934 | SEQ | C | Syndro | |
Cryopyrin-associated periodic syndrome 3 | CAPS3, CINCA syndrome | 607115 | NLRP3 | 606416 | SEQ, NGS | C | Fever | |
Currarino syndrom | 176450 | MNX1 | 142994 | SEQ, NGS | C | Syndro | ||
Cutaneous malignant melanoma-3 | CMM3 | 609048 | CDK4 only exon 2 and MLPA | 123829 | SEQ, MLPA | C | Neuro | |
Cystic fibrosis | CF, mucoviscidosis | 219700 | CFTR | 602421 | SEQ, MLPA, NGS | C | Meta | |
Darier-White disease | DAR, keratosis follicularis | 124200 | ATP2A2 | 108740 | SEQ, NGS | D | Geno | |
De Sanctis-Cacchione syndrome | 278800 | ERCC6 | 609413 | SEQ, NGS | D | Syndro | ||
Deafness, autosomal dominant type 8/12 | DFNA12/DFNA8 | 601543 | TECTA | 602574 | SEQ, NGS | D | Sensory | |
Deafness, autosomal dominant, type 13 | DFNA13 | 601868 | COL11A2 | 120290 | SEQ, NGS | D | Sensory | |
Deafness, autosomal dominant, type 2B | DFNA2B | 612644 | GJB3 | Connexin 31 | 603324 | SEQ, MLPA, NGS | D | Sensory |
Deafness, autosomal recessive type 21 | DFNB21 | 603629 | TECTA | 602574 | SEQ, NGS | D | Sensory | |
Deafness, autosomal recessive, type 1A | DFNB1A | 220290 | GJB2 | Connexin 26 | 121011 | SEQ, MLPA, NGS | D | Sensory |
Deafness, autosomal recessive, type 1B | DFNB1B | 612645 | GJB6, only CNV | Connexin 30 | 604418 | MLPA | D | Sensory |
Deafness, autosomal recessive, type 53 | DFNB53 | 609706 | COL11A2 | 120290 | SEQ, NGS | D | Sensory | |
Deafness, X-linked type 2 | DFNX2 | 304400 | POU3F4 | 300039 | SEQ, MLPA, NGS | D | Sensory | |
Deafness, X-linked, conductive with stapes fixation | DFN3 | 304400 | POU3F4 | 300039 | SEQ, MLPA, NGS | D | Sensory | |
Deafness, X-linked, type 1 | DFNX1 | 304500 | PRPS1 | 311850 | SEQ, NGS | D | Sensory | |
Deafness-optic atrophy plus syndrome | dominant optic atrophy plus syndrome, DOA+ | 125250 | OPA1 | 605290 | SEQ, MLPA, NGS | D | Sensory | |
Diabetes mellitus, noninsulin-dependent | NIDDM | 125853 | PPARG | 601487 | SEQ, MLPA, NGS | D | Meta | |
DiGeorge syndrome | 188400 | del22q11.2 | MLPA | D | Micro | |||
DiGeorge syndrome / velocardiofacial syndrome complex-2 | 601362 | del10p13-14 | MLPA | D | Micro | |||
Dihydropyrimidinase deficiency | DPYSD, Dihydropyrimidinuria | 222748 | DPYS | 613326 | SEQ, NGS | D | Meta | |
Dihydropyrimidine dehydrogenase deficiency | 274270 | DPYD exons 11, 13, 14 and 22 | 612779 | SEQ | D | Meta | ||
DOPA-responsive dystonia due to sepiapterin reductase deficiency | 612716 | SPR | 182125 | SEQ, NGS | D | Neuro | ||
DOPA-responsive dystonia, autosomal dominant | DRD, Segawa syndrome | 128230 | GCH1 | DYT5A | 600225 | SEQ, MLPA, NGS | D | Neuro |
DOPA-responsive dystonia, autosomal recessive | DRD, Segawa syndrome | 605407 | TH | DYT5B | 191290 | SEQ, MLPA, NGS | D | Neuro |
Dravet syndrome | Severe myoclonic epilepsy of infancy, SMEI | 607208 | SCN1A | 182389 | SEQ, MLPA, NGS | D | Epi | |
Du Pan syndrome | fibular hypoplasia and complex brachydactyly | 228900 | GDF5 | 601146 | SEQ, NGS | D | Tissue | |
Duane-radial ray syndrome | Okihiro syndrome | 607323 | SALL4 | 607343 | SEQ, MLPA, NGS | D | Syndro | |
Duchenne muscular dystrophy | DMD | 310200 | DMD | 300377 | SEQ, MLPA, NGS | D | Neuro | |
Dyschondrosteosis Leri-Weill type | LWD | 127300 | SHOX | 312865 | SEQ, MLPA, NGS | D | Tissue | |
Dyserythropoietic anemia, congenital, type IV | CDAN4 | 613673 | KLF1 | 600599 | SEQ, NGS | D | Coagul | |
Dystonia type 12 | DYT12 | 128235 | ATP1A3 | 182350 | SEQ, MLPA, NGS | D | Neuro | |
Dystonia-11, myoclonic | DYT11 | 159900 | SGCE | 604149 | SEQ, MLPA, NGS | D | Neuro | |
Early-onset vitelliform macular dystrophy | VMD2 | 153700 | BEST1 | 607854 | SEQ, MLPA, NGS | E | Sensory | |
EEC syndrome 3 | ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 | 604292 | TP63 | p63, TP73L | 603273 | SEQ, NGS | E | Syndro |
Ehlers-Danlos syndrome type IV | vascular type | 130050 | COL3A1 | 120180 | SEQ, MLPA, NGS | E | Tissue | |
Ehlers-Danlos syndrome, arthrochalasia type 1 | EDSARTH1 | 130060 | COL1A1 | 120150 | SEQ, MLPA, NGS | E | Tissue | |
Ehlers-Danlos syndrome, arthrochalasia type 2 | EDSARTH2 | 617821 | COL1A2 | 120160 | SEQ, MLPA, NGS | E | Tissue | |
Ehlers-Danlos syndrome, classic type 1 | EDSCL1 | 130000 | COL5A1 | 120215 | SEQ, MLPA, NGS | E | Tissue | |
Ehlers-Danlos syndrome, classic type 2 | EDSCL2 | 130010 | COL5A2 | 120190 | SEQ, NGS | E | Tissue | |
Ehlers-Danlos syndrome, musculocontractural type 1 | EDSMC1 | 601776 | CHST14 | 608429 | SEQ, NGS | E | Tissue | |
Eiken skeletal dysplasia | Eiken syndrome | 600002 | PTH1R | 168468 | SEQ, NGS | E | Tissue | |
Emery-Dreifuss muscular dystrophy type 1, X-linked | EDMD1 | 310300 | EMD | 300384 | SEQ, NGS | E | Neuro | |
Emery-Dreifuss muscular dystrophy type 2, autosomal dominant | 181350 | LMNA | Lamin-A/C | 150330 | SEQ, MLPA, NGS | E | Neuro | |
Emery-Dreifuss muscular dystrophy type 3, autosomal recessive | 616516 | LMNA | Lamin-A/C | 150330 | SEQ, MLPA, NGS | E | Neuro | |
Emery-Dreifuss muscular dystrophy type 6, X-linked Typ 6 | EDMD6 | 300696 | FHL1 | 300163 | SEQ, NGS | E | Neuro | |
Encephalopathy, neonatal severe | 300673 | MECP2 | 300005 | SEQ, MLPA, NGS | E | Syndro | ||
Epilepsy, female-restricted with mental retardation | EFMR, Juberg-Hellman syndrome | 300088 | PCDH19 | 300460 | SEQ, MLPA, NGS | E | Epi | |
Epileptic encephalopathy, early infantile, type 1 | EIEE1, X-linked infantile spasm syndrome, ISSX, West syndrome | 308350 | ARX | 300382 | SEQ, MLPA, NGS | E | Epi | |
Epileptic encephalopathy, early infantile, type 2 | EIEE2 | 300672 | CDKL5 | 300203 | SEQ, MLPA, NGS | E | Epi | |
Epileptic encephalopathy, early infantile, type 29 | EIEE29 | 616339 | AARS | 601065 | SEQ, NGS | E | Epi | |
Epiphyseal dysplasia, multiple, 2 | EDM2 | 600204 | COL9A2 | 120260 | SEQ, NGS | E | Tissue | |
Episodic ataxia type 1 | Episodic ataxia with myokymia | 160120 | KCNA1 | 176260 | SEQ, MLPA, NGS | E | Neuro | |
Episodic ataxia type 2 | episodic ataxia with myokymia | 108500 | CACNA1A | 601011 | SEQ, MLPA, NGS | E | Neuro | |
Episodic ataxia type 5 | EA5 | 613855 | CACNB4 | 601949 | SEQ, NGS | E | Neuro | |
Episodic ataxia type 6 | EA6 | 612656 | SLC1A3 | 600111 | SEQ, NGS | E | Neuro | |
Erythromelalgia, primary | erythermalgia | 133020 | SCN9A | 603415 | SEQ, NGS | E | Neuro | |
Exostoses, multiple, type 1 | multiple hereditary exostoses type 1 | 133700 | EXT1 | 608177 | SEQ, MLPA, NGS | E | Tissue | |
Exostoses, multiple, type 2 | multiple hereditary exostoses type 2 | 133701 | EXT2 | 608210 | SEQ, MLPA, NGS | E | Tissue | |
Fabry disease | 301500 | GLA | 300644 | SEQ, MLPA, NGS | F | Meta | ||
Facial dysmorphism, immunodeficiency, livedo and short stature | FILS syndrome | 615139 | POLE | 174762 | SEQ, NGS | F | Syndro | |
Factor II defect | Prothrombin | 188050 | F2 G20210A | Factor II | 176930 | SEQ | F | Coagul |
Factor IX deficiency | Hemophilia B, Christmas disease | 306900 | F9 | Factor IX | 300746 | SEQ, MLPA, NGS | F | Coagul |
Factor V deficiency | Factor V Leiden mutation | 188055 | F5 FVL mutation | Factor V | 612309 | SEQ | F | Coagul |
Factor VII deficiency | Hypoproconvertinemia | 227500 | F7 | Factor VII | 613878 | SEQ, MLPA, NGS | F | Coagul |
Factor XI deficiency | Hemophilia C, plasma thromboplastin antecedent | 612416 | F11 | 264900 | SEQ, MLPA, NGS | F | Coagul | |
Factor XII deficiency | Hageman factor deficiency | 234000 | F12 | 610619 | SEQ, MLPA, NGS | F | Coagul | |
Failure of tooth eruption, primary, nonsyndromic | 125350 | PTH1R | 168468 | SEQ, NGS | F | Tissue | ||
Familial adenomatous polyposis coli, familial polyposis of the colon | FAP | 175100 | APC | 611731 | SEQ, MLPA, NGS | F | Tumor | |
Familial adenomatous polyposis coli, familial polyposis of the colon, type 3 | FAP3 | 616415 | NTHL1 | 602656 | SEQ, NGS | F | Tumor | |
Familial adenomatous polyposis coli, familial polyposis of the colon, type 4 | FAP4 | 617100 | MSH3 | 600887 | SEQ, NGS | F | Tumor | |
Familial atypical mole-malignant melanoma syndrome | FAMMM, cutaneous malignant melanoma-1, CMM1, familial melanoma, MLM | 155600 | CDK4 exon 2 | 123829 | SEQ | F | Tumor | |
Familial atypical mole-malignant melanoma syndrome | FAMMM, familial melanoma, MLM | 155600 | CDKN2A | 600160 | SEQ, MLPA, NGS | F | Tumor | |
Familial breast cancer | 114480 | ATM | 607585 | SEQ, MLPA, NGS | F | Tumor | ||
Familial breast cancer | 114480 | CHEK2 | 604373 | SEQ, MLPA, NGS | F | Tumor | ||
Familial breast-ovarian cancer type 1 | HBOC1 | 604370 | BRCA1 | 113705 | SEQ, MLPA, NGS | F | Tumor | |
Familial breast-ovarian cancer type 2 | HBOC2 | 612555 | BRCA2 | 600185 | SEQ, MLPA, NGS | F | Tumor | |
Familial breast-ovarian cancer type 3 | HBOC3 | 613399 | RAD51C | FANCO | 602774 | SEQ, MLPA, NGS | F | Tumor |
Familial breast-ovarian cancer type 4 | HBOC4 | 614291 | RAD51D | 602954 | SEQ, MLPA, NGS | F | Tumor | |
Familial cold autoinflammatory syndrome | FCAS, cryopyrin-associated periodic syndrome 1, CAPS1 | 120100 | NLRP3 | 606416 | SEQ, NGS | F | Fever | |
Familial gestational hyperthyroidism | 603373 | TSHR | 603372 | SEQ, MLPA, NGS | F | Meta | ||
Familial hemiplegic migraine type 1 | FHM1 | 141500 | CACNA1A | 601011 | SEQ, MLPA, NGS | F | Neuro | |
Familial hemiplegic migraine type 2 | FHM2 | 602481 | ATP1A2 | 182340 | SEQ, MLPA, NGS | F | Neuro | |
Familial hemiplegic migraine type 3 | FHM3 | 609634 | SCN1A | 182389 | SEQ, MLPA, NGS | F | Neuro | |
Familial mediterranean fever, dominant or recessive | FMF, autosomal dominant /autosomal recessive | 134610 / 249100 | MEFV | 608107 | SEQ, MLPA, NGS | F | Fever | |
Familial medullary thyroid carcinoma | FMTC | 155240 | RET | 164761 | SEQ, MLPA, NGS | F | Tumor | |
Familial periodic fever | tumor necrosis factor receptor-associated periodic syndrome (TRAPS) | 142680 | TNFRSF1A | 191190 | SEQ, NGS | F | Fever | |
Fatal familial insomnia | FFI | 600072 | PRNP | 176640 | SEQ, NGS | F | Neuro | |
Fibrochondrogenesis type 1 | FBCG1 | 228520 | COL11A1 | 120280 | SEQ, MLPA, NGS | F | Tissue | |
Fibrochondrogenesis type 2 | FBCG2 | 614524 | COL11A2 | 120290 | SEQ, NGS | F | Tissue | |
Floating-Harbor syndrome | FHS | 136140 | SRCAP exon 30 to 34 | 611421 | SEQ | F | Syndro | |
Focal dermal hypoplasia | Goltz-Gorlin syndrome | 305600 | PORCN | 300651 | SEQ, NGS | F | Syndro | |
Foveal hypoplasia | FVH1 | 136520 | PAX6 | 607108 | SEQ, MLPA, NGS | F | Sensory | |
Frank-ter Haar syndrome | FTHS | 249420 | SH3PXD2B | 613293 | SEQ, NGS | F | Syndro | |
Friedreich ataxia | Friedreich disease, FRDA | 229300 | FXN repeat | 606829 | REP | F | Neuro | |
Frontotemporal dementia | FTD | 600274 | MAPT | 157140 | SEQ, MLPA, NGS | F | Neuro | |
Frontotemporal dementia and/or amyotrophic lateral sclerosis | FTDALS1 | 105550 | C9orf72 repeat | 614260 | REP | F | Neuro | |
Frontotemporal dementia type 3 | FTD3 | 600795 | CHMP2B | 609512 | SEQ, NGS | F | Neuro | |
Frontotemporal dementia with parkinsonism | Multiple system tauopathy with presenile dementia, FTD17 | 600274 | MAPT | 157140 | SEQ, MLPA, NGS | F | Neuro | |
Frontotemporal dementia with TDP43 inclusions | 612069 | TARDBP | TDP43 | 605078 | SEQ, NGS | F | Neuro | |
Frontotemporal lobar degeneration with TDP43 inclusions | FTLD-TDP, Frontotemporal dementia, ubiquitin-positive, FTDU | 607485 | GRN | PGRN | 138945 | SEQ, MLPA, NGS | F | Neuro |
Fructose intolerance, hereditary | Fructosemia, aldolase B deficiency | 229600 | ALDOB | 612724 | SEQ, MLPA, NGS | F | Meta | |
Fumarase deficiency | Fumaric aciduria | 606812 | FH | 136850 | SEQ, MLPA, NGS | F | Meta | |
Galactosemia | GALAC1 | 230400 | GALT | 606999 | SEQ, MLPA, NGS | G | Meta | |
Generalized epilepsy with febrile seizures plus, type 1 | GEFS+1 | 604233 | SCN1B | 600235 | SEQ, NGS | G | Epi | |
Generalized epilepsy with febrile seizures plus, type 2 | GEFS+2 | 604403 | SCN1A | 182389 | SEQ, MLPA, NGS | G | Epi | |
Generalized epilepsy with febrile seizures plus, type 7 | GEFS+7 | 613863 | SCN9A | 603415 | SEQ, NGS | G | Epi | |
Gerstmann-Sträussler-Scheinker syndrome | GSSS | 137440 | PRNP | 176640 | SEQ, NGS | G | Neuro | |
Gilbert syndrome | 143500 | UGT1A1 | UGT1 | 191740 | SEQ, NGS | G | Meta | |
Gillespie syndrome | GLSP | 206700 | ITPR1 | 147265 | SEQ, MLPA, NGS | G | Neuro | |
Glass syndrome | SATB2-associated syndrome | 612313 | SATB2 | 608148 | SEQ, MLPA, NGS | G | Syndro | |
Glomerulocystic kidney disease with hyperuricemia and isosthenuria | 609886 | UMOD | 191845 | SEQ, NGS | G | Meta | ||
Glomuvenous malformations | glomangiomas | 138000 | GLMN | 601749 | SEQ, NGS | G | Tumor | |
Glucose transport defect, blood-brain barrier | GLUT1-deficiency syndrome 1 | 606777 | SLC2A1 | GLUT1 | 138140 | SEQ, MLPA, NGS | G | Neuro |
GLUT1 deficiency syndrome 1 | GLUT1DS1 | 606777 | SLC2A1 | GLUT1 | 138140 | SEQ, MLPA, NGS | G | Epi |
Glycine encephalopathy | GCE, Hyperglycinemia nonketotic (NKH) | 605899 | AMT | GCST | 238310 | SEQ, MLPA, NGS | G | Meta |
Glycogen storage disease IV | GSD4, Andersen disease | 232500 | GBE1 | 607839 | SEQ, NGS | G | Meta | |
Glycogen storage disease V | GSD5, McArdle disease | 232600 | PYGM | 608455 | SEQ, NGS | G | Meta | |
Gnathodiaphyseal dysplasia | GDD | 166260 | ANO5 | 608662 | SEQ, MLPA, NGS | G | Syndro | |
Greig cephalopolysyndactyly syndrome | Polysyndactyly with peculiar skull shape | 175700 | GLI3 | 165240 | SEQ, NGS | G | Syndro | |
Gusher syndrome | 304400 | POU3F4 | 300039 | SEQ, MLPA, NGS | G | Sensory | ||
Hailey-Hailey disease | Benign familial pemphigus, BCPM | 169600 | ATP2C1 | 604384 | SEQ, NGS | H | Geno | |
HARP syndrome | Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration | 607236 | PANK2 | 606157 | SEQ, MLPA, NGS | H | Syndro | |
Hartnup disorder | HND | 234500 | SLC6A19 | 608893 | SEQ, NGS | H | Meta | |
Hematuria, familial benign | Thin-basement-membrane nephropathy, TBMN | 141200 | COL4A3 | 120070 | SEQ, MLPA, NGS | H | Kidney | |
Hematuria, familial benign | Thin-basement-membrane nephropathy, TBMN | 141200 | COL4A3 | 120070 | SEQ, MLPA, NGS | H | Syndro | |
Hemochromatosis | 235200 | HFE exon 2 and exon 4 | 613609 | SEQ | H | Meta | ||
Hennekam syndrome | Hennekam lymphangiectasia-lymphedema syndrome, HKLLS1 | 235510 | CCBE1 | 612753 | SEQ, NGS | H | Syndro | |
Hereditary diffuse gastric cancer | 137215 | CDH1 | 192090 | SEQ, MLPA, NGS | H | Tumor | ||
Hereditary endotheliopathy with retinopathy, nephropathy, and stroke | HERNS syndrome | 192315 | TREX1 | 606609 | SEQ, MLPA, NGS | H | Syndro | |
Hereditary leiomyomatosis and renal cell cancer | HLRCC | 150800 | FH | 136850 | SEQ, MLPA, NGS | H | Tumor | |
Hereditary leiomyomatosis and renal cell cancer | HLRCC | 150800 | FH | 136850 | SEQ, MLPA, NGS | L | Kidney | |
Hereditary mixed polyposis syndrome type 1 | HMPS1 | 601228 | GREM1 only CNV-analysis | 603054 | MLPA, NGS | H | Tumor | |
Hereditary mixed polyposis syndrome type 2 | HMPS2 | 610069 | BMPR1A | 601299 | SEQ, MLPA, NGS | H | Tumor | |
Hereditary motor neuropathy type VB, distal | HMN5B | 614751 | REEP1 | 609139 | SEQ, MLPA, NGS | H | Neuro | |
Hereditary neuralgic amyotrophy | HNA | 162100 | Sept.9 | 604061 | SEQ, NGS | H | Neuro | |
Hereditary nonpolyposis colorectal cancer type I | HNPCC, Lynch syndrome | 120435 | MSH2 | 609309 | SEQ, MLPA, NGS | H | Tumor | |
Hereditary nonpolyposis colorectal cancer type II | HNPCC, Lynch syndrome | 609310 | MLH1 | 120436 | SEQ, MLPA, NGS | H | Tumor | |
Hereditary nonpolyposis colorectal cancer type IV | HNPCC, Lynch syndrome | 614337 | PMS2 | 600259 | SEQ, MLPA, NGS | H | Tumor | |
Hereditary nonpolyposis colorectal cancer type V | HNPCC, Lynch syndrome | 614350 | MSH6 | 600678 | SEQ, MLPA, NGS | H | Tumor | |
Hereditary pancreatitis | PCTT | 167800 | CFTR | 602421 | SEQ, MLPA, NGS | H | Tumor | |
Hereditary pancreatitis | PCTT | 167800 | CTRC | 601405 | SEQ, NGS | H | Tumor | |
Hereditary pancreatitis | PCTT | 167800 | PRSS1 | 276000 | SEQ, MLPA, NGS | H | Tumor | |
Hereditary pancreatitis | PCTT | 167800 | SPINK1 | 167790 | SEQ, MLPA, NGS | H | Tumor | |
Hereditary persistence of fetal hemoglobin type 6 | HBFQTL6 | 613566 | KLF1 | 600599 | SEQ, NGS | H | Coagul | |
Hereditary, sensory and autonomic neuropathy type IA | HSAN1A, HSN1A | 162400 | SPTLC1 | 605712 | SEQ, MLPA, NGS | H | Neuro | |
Hereditay neuropathy with pressure palsies | HNPP, tomaculous neuropathy | 162500 | PMP22 | 601097 | SEQ, MLPA, NGS | H | Neuro | |
Hirschsprung disease type 1 | HSCR1 | 142623 | RET | 164761 | SEQ, MLPA, NGS | H | Syndro | |
Hirschsprung disease type 2 | HSCR2 | 600155 | EDNRB | 131244 | SEQ, MLPA, NGS | H | Syndro | |
Hirschsprung disease type 4 | HSCR4 | 613712 | EDN3 | 131242 | SEQ, MLPA, NGS | H | Syndro | |
Holt-Oram syndrome | HOS | 142900 | TBX5 | 601620 | SEQ, MLPA, NGS | H | Syndro | |
Homocystinuria due to MTHFR deficiency | 236250 | MTHFR c.677C>T and c.1298A>C | 607093 | SEQ | H | Coagul | ||
Huntington disease | HD, Huntington chorea | 143100 | HTT repeat | 613004 | REP | H | Neuro | |
Huntington disease-like 1 | HDL1 | 603218 | PRNP | 176640 | SEQ, NGS | H | Neuro | |
Huntington disease-like 2 | HDL2 | 606438 | JPH3 repeat | 605268 | REP | H | Neuro | |
Huntington disease-like 4 | HDL4 | 607136 | TBP repeat | 600075 | REP | H | Neuro | |
Hutchinson-Gilford progeria syndrome, childhood-onset | 176670 | LMNA | 150330 | SEQ, MLPA, NGS | H | Syndro | ||
Hydrocephalus, X-linked | Hydrocephalus due to congenital stenosis of aqueduct of sylvius | 307000 | L1CAM | 308840 | SEQ, MLPA, NGS | H | Syndro | |
Hypercholesterolemia, familial, 3 | FHCL3 | 603776 | PCSK9 | 607786 | SEQ, NGS | H | Meta | |
Hypercholesterolemia, familial, type 1 | FHCL1, Hyperlipoproteinemia, type IIA | 143890 | LDLR | 606945 | SEQ, MLPA, NGS | H | Meta | |
Hypercholesterolemia, familial, type 2 | FHCL2 | 144010 | APOB p.R3527Q [R3500Q], p.R3558C [R3531C] | 107730 | SEQ | H | Meta | |
Hypercholesterolemia, familial, type 4 | FHCL4, autosomal recessive | 603813 | LDLRAP1 | 605747 | SEQ, NGS | H | Meta | |
Hyperferritinemia-cataract syndrome | 600886 | FTL | 134790 | SEQ, NGS | H | Meta | ||
Hyperferritinemia-cataract syndrome | 600886 | FTL | 134790 | SEQ, NGS | H | Sensory | ||
Hyperferritinemia-cataract syndrome | 600886 | FTL | 134790 | SEQ, NGS | H | Syndro | ||
Hyper-IgD syndrome | HIDS, hyperimmunoglobulinemia D and periodic fever, mevalonat kinase deficiency | 260920 | MVK | 251170 | SEQ, NGS | H | Fever | |
Hyper-IgE recurrent infection syndrome, autosomal dominant | HIES, Job syndrome | 147060 | STAT3 | 102582 | SEQ, MLPA, NGS | H | Meta | |
Hyper-IgE syndrome with atypical mycobacteriosis, autosomal recessive | Immunodeficiency 35, tyrosine kinase 2 deficiency | 611521 | TYK2 | 176941 | SEQ, NGS | H | Meta | |
Hyper-IgE syndrome, autosomal recessive | Immunodeficiency 23 | 615816 | PGM3 | 172100 | SEQ, NGS | H | Meta | |
Hyperinsulinemic hypoglycemia, familial, type 1 | HHF1, hyperinsulinism, familial type 1 | 256450 | ABCC8 | SUR1 | 600509 | SEQ, MLPA, NGS | H | Meta |
Hyperinsulinemic hypoglycemia, familial, type 2 | HHF2, hyperinsulinism, familial type 2 | 601820 | KCNJ11 | Kir6.2 | 600937 | SEQ, NGS | H | Meta |
Hyperinsulinemic hypoglycemia, familial, type 3 | HHF3, hyperinsulinism, familial type 3 | 602485 | GCK | 138079 | SEQ, MLPA, NGS | H | Meta | |
Hyperinsulinemic hypoglycemia, familial, type 4 | HHF4, hyperinsulinism, familial type 4 | 609975 | HADH | 601609 | SEQ, NGS | H | Meta | |
Hyperinsulinemic hypoglycemia, familial, type 6 | HHF6, Hyperinsulinism-hyperammonemia syndrome | 606762 | GLUD1 | 138130 | SEQ, NGS | H | Meta | |
Hyperinsulinemic hypoglycemia, familial, type 6 | HHF6, Hyperinsulinism-hyperammonemia syndrome | 606762 | GLUD1 | 138130 | SEQ, NGS | H | Path | |
Hyperkalemic periodic paralysis type 2 | HYPP | 170500 | SCN4A | 603967 | SEQ, MLPA, NGS | H | Neuro | |
Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome | HHH syndrome | 238970 | SLC25A15 | 603861 | SEQ, NGS | H | Meta | |
Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome | HHH syndrome | 238970 | SLC25A15 | 603861 | SEQ, NGS | H | Path | |
Hyperphosphatasia with mental retardation syndrome 1 | Mabry syndrome | 239300 | PIGV | 610274 | SEQ, NGS | H | Syndro | |
Hyperprolinemia, type I | HYRPRO1 | 239500 | PRODH | 606810 | SEQ, NGS | H | Meta | |
Hyperprolinemia, type II | HYRPRO2, P5CDH1-Defizienz | 239510 | ALDH4A1 | P5CDH | 606811 | SEQ, NGS | H | Meta |
Hyperuricemic nephropathy, familial juvenile, 1 | HNFJ1 | 162000 | UMOD | 191845 | SEQ, NGS | H | Meta | |
Hypochondroplasia | HCH | 146000 | FGFR3 | 134934 | SEQ, MLPA, NGS | H | Tissue | |
Hypodontia/oligodontia type 1 | Tooth agenesis, selective, with or without orofacial cleft, STHAG1 | 106600 | MSX1 | 142983 | SEQ, NGS | H | Syndro | |
Hypogonadotropic hypogonadism with or without anosmia 12 | HH12 | 614841 | GNRH1 | 152760 | SEQ, MLPA, NGS | H | Syndro | |
Hypogonadotropic hypogonadism with or without anosmia 7 | HH7, idiopathic hypogonadotropic hypogonadism | 146110 | GNRHR | 138850 | SEQ, MLPA, NGS | H | Syndro | |
Hypogonadotropic hypogonadism with or without anosmia 8 | HH8 | 614837 | KISS1R | 604161 | SEQ, MLPA, NGS | H | Syndro | |
Hypokalemic periodic paralysis type 1 | HOKPP1 | 170400 | CACNA1S | 114208 | SEQ, MLPA, NGS | H | Neuro | |
Hypokalemic periodic paralysis type 2 | HOKPP2 | 613345 | SCN4A | 603967 | SEQ, MLPA, NGS | H | Neuro | |
Hypophosphatasia, adult | HPPA | 146300 | ALPL | 171760 | SEQ, MLPA, NGS | H | Meta | |
Hypophosphatasia, childhood | HPPC | 241510 | ALPL | 171760 | SEQ, MLPA, NGS | H | Meta | |
Hypophosphatasia, infantile | HPPI | 241500 | ALPL | 171760 | SEQ, MLPA, NGS | H | Meta | |
Idiopathic generalized epilepsy, susceptibility to, 9 | EIG9 | 607682 | CACNB4 | 601949 | SEQ, NGS | I | Epi | |
Immunodeficiency, common variable, type 1 | CVID1, antibody deficiency due to icos defect | 607594 | ICOS | 604558 | SEQ, NGS | I | Meta | |
Immunodeficiency, common variable, type 2 | CVID2, antibody deficiency, hypogammaglobulinemia due to taci defect | 240500 | TNFRSF13B | TACI | 604907 | SEQ, NGS | I | Meta |
Immunoglobulin A deficiency type 2 | IGAD2 | 609529 | TNFRSF13B | TACI | 604907 | SEQ, NGS | I | Meta |
Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia | IBMPFD1 | 167320 | VCP | 601023 | SEQ, NGS | I | Neuro | |
Infantile, familial convulsions with paroxysmal choreoathetosis | ICCA | 602066 | PRRT2 | 614386 | SEQ, MLPA, NGS | I | Neuro | |
Infantile-onset spinocerebellar ataxia, autosomal recessive | 271245 | TWNK | C10ORF2, TWINKLE | 606075 | SEQ, MLPA, NGS | I | Neuro | |
Insensitivity to pain, congenital, autosomal recessive | congenital indifference to pain, autosomal recessive, CIP | 243000 | SCN9A | 603415 | SEQ, NGS | I | Neuro | |
Intervertebral disc disease | IDD | 603932 | COL9A3 c.280C>T, c.307C>T | 120270 | SEQ | I | Tissue | |
Intracardiac myxoma | 255960 | PRKAR1A | 188830 | SEQ, MLPA, NGS | I | Tumor | ||
Intractable childhood epilepsy with generalized tonic-clonic seizures | ICEGTC | 607208 | SCN1A | 182389 | SEQ, MLPA, NGS | I | Epi | |
Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies | IMAGE syndrome | 614732 | CDKN1C | KIP2 | 600856 | SEQ, MLPA, NGS | I | Syndro |
Iron-refractory iron deficiency anemia | IRIDA | 206200 | TMPRSS6 | 609862 | SEQ, NGS | I | Meta | |
IVIC syndrome | 147750 | SALL4 | 607343 | SEQ, MLPA, NGS | I | Syndro | ||
Jackson-Weiss syndrome | Craniosynostosis, midfacial hypoplasia, and foot abnormalities | 123150 | FGFR1 | 136350 | SEQ, MLPA, NGS | J | Syndro | |
Jacobsen syndrome | chromosome 11q deletion syndrome | 147791 | del11q23 | MLPA | J | Micro | ||
Jervell and Lange-Nielsen syndrome type 1 | JLNS1, prolongation of the QT interval + congenital deafness | 220400 | KCNQ1 | 607542 | SEQ, MLPA, NGS | J | Cardio | |
Jervell and Lange-Nielsen syndrome type 2 | JLNS2 | 612347 | KCNE1 | 176261 | SEQ, MLPA, NGS | J | Cardio | |
Joubert syndrome type 10 | JBTS10 | 300804 | OFD1 | 300170 | SEQ, NGS | J | Syndro | |
Juvenile myoclonus epilepsy, susceptibility, 6 | EJM6 | 607682 | CACNB4 | 601949 | SEQ, NGS | J | Epi | |
Juvenile polyposis with hereditary hemorrhagic teleangiectasia syndrome | JP/HHT | 175050 | SMAD4 | MADH4 | 600993 | SEQ, MLPA, NGS | J | Tumor |
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome | JP/HHT | 175050 | SMAD4 | MADH4 | 600993 | SEQ, MLPA, NGS | J | Tissue |
Juvenile, intestinal polyposis | JIP | 174900 | BMPR1A | 601299 | SEQ, MLPA, NGS | J | Tumor | |
Juvenile, intestinal polyposis | JIP | 174900 | SMAD4 | MADH4 | 600993 | SEQ, MLPA, NGS | J | Tumor |
Kallmann syndrome 1 | Hypogonadotropic hypogonadism 1 with or without anosmia, HH1 | 308700 | ANOS1 | KAL1 | 300836 | SEQ, MLPA, NGS | K | Syndro |
Kallmann syndrome 2 | Hypogonadotropic hypogonadism 2 with or without anosmia | 147950 | FGFR1 | 136350 | SEQ, MLPA, NGS | K | Syndro | |
Kelley-Seegmiller syndrome | HPRT-related gout/hyperuricemia | 300323 | HPRT1 | 308000 | SEQ, MLPA, NGS | K | Meta | |
Kleefstra syndrome | 610253 | EHMT1 | 607001 | SEQ, MLPA, NGS | K | Syndro | ||
Klippel-Feil syndrome 1, autosomal dominant | KFS1 | 118100 | GDF6 | 601147 | SEQ, NGS | K | Syndro | |
Klippel-Feil syndrome 2, autosomal recessive | KFS2 | 214300 | MEOX1 | 600147 | SEQ, NGS | K | Syndro | |
Klippel-Feil syndrome 3, autosomal dominant | KFS3 | 613702 | GDF3 | 606522 | SEQ, NGS | K | Syndro | |
Klippel-Trenaunay-Weber syndrome, predisposition | KTS | 149000 | AGGF1, mutation exon 3: c.397G>A, p.E133K [VG5Q] | 608464 | SEQ | K | Syndro | |
Kniest dysplasia | 156550 | COL2A1 | 120140 | SEQ, MLPA, NGS | K | Tissue | ||
Lactase deficiency, congenital | alactasia, congenital | 223000 | LCT complete gene | 603202 | SEQ, MLPA, NGS | L | Meta | |
Lactose intolerance | 223100 | LCT c.1-13910T/C | 603202 | SEQ | L | Meta | ||
Langer-Giedion syndrome | trichorhinophalangeal syndrome, type II | 150230 | del8q24.11-q24.13 (TRPS1, EXT1 genes) | 604386, 608177 | MLPA | L | Micro | |
Laurence-Moon syndrome | LNMS | 245800 | PNPLA6 | 603197 | SEQ, NGS | L | Neuro | |
Leber congenital amaurosis type 17 | LCA17 | 615360 | GDF6 | 601147 | SEQ, NGS | L | Sensory | |
Leber congenital amaurosis type 18 | LCA18 | 608133 | PRPH2 | 179605 | SEQ, MLPA, NGS | L | Sensory | |
Leber hereditary optic neuropathy | LHON | 535000 | MT-ATP6 | 516060 | SEQ, NGS | L | Sensory | |
Leber hereditary optic neuropathy | LHON | 535000 | MT-ND1 | 516000 | SEQ, NGS | L | Sensory | |
Leber hereditary optic neuropathy | LHON | 535000 | MT-ND3 | 516002 | SEQ, NGS | L | Sensory | |
Leber hereditary optic neuropathy | LHON | 535000 | MT-ND4 | 516003 | SEQ, NGS | L | Sensory | |
Leber hereditary optic neuropathy | LHON | 535000 | MT-ND4L | 516004 | SEQ, NGS | L | Sensory | |
Leber hereditary optic neuropathy | LHON | 535000 | MT-ND5 | 516005 | SEQ, NGS | L | Sensory | |
Leber hereditary optic neuropathy | LHON | 535000 | MT-ND6 | 516006 | SEQ, NGS | L | Sensory | |
Leber hereditary optic neuropathy | LHON | 535000 | MT-TL1 | 590050 | SEQ, NGS | L | Sensory | |
Legius syndrome | Neurofibromatosis type 1-like syndrome | 611431 | SPRED1 | 609291 | SEQ, MLPA, NGS | L | Syndro | |
Leigh syndrome | 256000 | MT-ATP6 | 516060 | SEQ, NGS | L | Neuro | ||
Leigh syndrome | 256000 | MT-ND5 | 516005 | SEQ, NGS | L | Neuro | ||
Leigh syndrome | 256000 | MT-ND6 | 516006 | SEQ, NGS | L | Neuro | ||
Leigh syndrome | 256000 | SDHA | 600857 | SEQ, MLPA, NGS | L | Neuro | ||
LEOPARD syndrome 1 | 151100 | PTPN11 | 176876 | SEQ, NGS | L | Syndro | ||
LEOPARD syndrome 2 | 611554 | RAF1 | 164760 | SEQ, NGS | L | Syndro | ||
LEOPARD syndrome 3 | LPRD3 | 613707 | BRAF | 164757 | SEQ, NGS | L | Syndro | |
Lesch-Nyhan syndrome | 300322 | HPRT1 | 308000 | SEQ, MLPA, NGS | L | Meta | ||
Leukemia, acute lymphoblastic type 3, susceptibility | ALL3 | 615545 | PAX5 | 167414 | SEQ, NGS | L | Tumor | |
Leukoencephalopathy with vanishing white matter | VWM | 603896 | EIF2B2 | 606454 | SEQ, NGS | L | Neuro | |
Leukoencephalopathy with vanishing white matter | VWM | 603896 | EIF2B5 | 603945 | SEQ, NGS | L | Neuro | |
Lewy-Body dementia | Lewy-Body variant of Alzheimer disease | 127750 | SNCA | 163890 | SEQ, MLPA, NGS | L | Neuro | |
Lewy-Body dementia | Lewy-Body variant of Alzheimer disease | 127750 | SNCB | 602569 | SEQ, NGS | L | Neuro | |
L-Ferritin deficiency | LFTD | 615604 | FTL | 134790 | SEQ, NGS | L | Meta | |
Lhermitte-Duclos syndrome | 158350 | PTEN | 601728 | SEQ, MLPA, NGS | L | Tumor | ||
Li-Fraumeni syndrome 1 | LFS1 | 151623 | TP53 | 191170 | SEQ, MLPA, NGS | L | Tumor | |
Li-Fraumeni syndrome 2 | LFS2 | 609265 | CHEK2 | 604373 | SEQ, MLPA, NGS | L | Tumor | |
Limb-mammary syndrome | 603543 | TP63 | p63, TP73L | 603273 | SEQ, NGS | L | Syndro | |
Lipodystrophy, congenital generalized, type 1 | CGL1, Berardinelli-Seip syndrome | 608594 | AGPAT2 | 603100 | SEQ, NGS | L | Meta | |
Lipodystrophy, congenital generalized, type 2 | CGL2, Berardinelli-Seip syndrome | 269700 | BSCL2 | 606158 | SEQ, NGS | B | Tissue | |
Lipodystrophy, congenital generalized, type 2 | CGL2, Berardinelli-Seip syndrome | 269700 | BSCL2 | 606158 | SEQ, NGS | L | Meta | |
Lipodystrophy, congenital generalized, type 3 | CGL3, Berardinelli-Seip syndrome | 612526 | CAV1 | 601047 | SEQ, NGS | L | Meta | |
Lipodystrophy, familial partial, type 2 | FPLD2, Lipodystrophy type Dunnigan | 151660 | LMNA | 150330 | SEQ, MLPA, NGS | L | Meta | |
Lipodystrophy, familial partial, type 2 | FPLD2, Lipodystrophy type Dunnigan | 151660 | LMNA | 150330 | SEQ, MLPA, NGS | L | Syndro | |
Lipodystrophy, familial partial, type 3 | FPLD3 | 604367 | PPARG | 601487 | SEQ, MLPA, NGS | L | Meta | |
Lipodystrophy, familial partial, type 4 | FPLD4 | 613877 | PLIN1 | 170290 | SEQ, NGS | L | Meta | |
Lipodystrophy, familial partial, type 5 | FPLD5 | 615238 | CIDEC | 612120 | SEQ, NGS | L | Meta | |
Lipodystrophy, familial partial, type 7 | FPLD7, lipodystrophy congenital cataracts, with or without neurodegeneration syndrome (LCCNS) | 606721 | CAV1 | 601047 | SEQ, NGS | L | Meta | |
Lipodystrophy, partial, acquired, susceptibility | APLD, Barraquer-Simons syndrome | 608709 | LMNB2 | 150341 | SEQ, NGS | L | Meta | |
Lissencephaly (X-linked) with ambiguous genitalia | 300215 | ARX | 300382 | SEQ, MLPA, NGS | L | Syndro | ||
Lissencephaly type 1 | LIS1 | 607432 | PAFAH1B1 | LIS1 | 601545 | SEQ, MLPA, NGS | L | Syndro |
Lissencephaly type 3 | LIS3 | 611603 | TUBA1A | 602529 | SEQ, NGS | L | Syndro | |
Lissencephaly, X-linked | LISX1 | 300067 | DCX | 300121 | SEQ, MLPA, NGS | L | Syndro | |
Loeys-Dietz syndrome type 1 | LDS1, Furlong syndrome | 609192 | TGFBR1 | 190181 | SEQ, MLPA, NGS | L | Tissue | |
Loeys-Dietz syndrome type 2 | LDS2 | 610168 | TGFBR2 | 190182 | SEQ, MLPA, NGS | L | Tissue | |
Loeys-Dietz syndrome type 3 | LDS3, aneurysms-osteoarthritis syndrome | 613795 | SMAD3 | 603109 | SEQ, NGS | L | Tissue | |
Loeys-Dietz syndrome type 4 | LDS4 | 614816 | TGFB2 | 190220 | SEQ, NGS | L | Tissue | |
Loeys-Dietz syndrome type 5 | LDS5 | 615582 | TGFB3 | 190230 | SEQ, MLPA, NGS | L | Tissue | |
Long QT syndrome 1 | LQT1, Romano-Ward syndrome 1 | 192500 | KCNQ1 | 607542 | SEQ, MLPA, NGS | L | Cardio | |
Long QT syndrome 16 | LQT16 | 618782 | CALM3 | 114183 | SEQ, NGS | L | Cardio | |
Long QT syndrome 2 | LQT2, Romano-Ward syndrome 2 | 613688 | KCNH2 | 152427 | SEQ, MLPA, NGS | L | Cardio | |
Long QT syndrome 3 | LQT3, Romano-Ward syndrome 3 | 603830 | SCN5A | 600163 | SEQ, MLPA, NGS | L | Cardio | |
Long QT syndrome 5 | LQT5 | 613695 | KCNE1 | 176261 | SEQ, MLPA, NGS | L | Cardio | |
Long QT syndrome 6 | LQT6 | 613693 | KCNE2 | 603796 | SEQ, MLPA, NGS | L | Cardio | |
Long QT syndrome 7 | LQT7, Anderson-Tawil syndrome | 170390 | KCNJ2 | 600681 | SEQ, MLPA, NGS | L | Cardio | |
Long QT syndrome 9 | LQT9 | 611818 | CAV3 | 601253 | SEQ, MLPA, NGS | L | Cardio | |
Lowe syndrome | Oculocerebrorenal syndrome | 309000 | OCRL | 300535 | SEQ, NGS | L | Syndro | |
Makrozephalie-Makrosomie-Faziale Dysmorphie-Syndrom | Chromosome 17q11.2 deletion syndrome | 613675 | RNF135 | SEQ, NGS | M | Syndro | ||
Malignant hyperthermia susceptibility 5 | MHS5 | 601887 | CACNA1S | 114208 | SEQ, MLPA, NGS | M | Meta | |
Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome | MDPL | 615381 | POLD1 | 174761 | SEQ, NGS | M | Syndro | |
Mandibuloacral dysplasia with type a lipodystrophy | MADA | 248370 | LMNA | 150330 | SEQ, MLPA, NGS | M | Syndro | |
Marfan syndrome | MFS, MFS1 | 154700 | FBN1 | 134797 | SEQ, MLPA, NGS | M | Tissue | |
Marinesco-Sjorgren syndrome | MSS | 248800 | SIL1 | 608005 | SEQ, NGS | M | Neuro | |
Marshall syndrome | MRSHS | 154780 | COL11A1 | 120280 | SEQ, MLPA, NGS | M | Tissue | |
Maturity-onset diabetes of the young, type 1 | MODY1 | 125850 | HNF4A | 600281 | SEQ, MLPA, NGS | M | Meta | |
Maturity-onset diabetes of the young, type 2 | MODY2 | 125851 | GCK | 138079 | SEQ, MLPA, NGS | M | Meta | |
Maturity-onset diabetes of the young, type 3 | MODY3 | 600496 | HNF1A | TCF1 | 142410 | SEQ, MLPA, NGS | M | Meta |
Maturity-onset diabetes of the young, type 4 | MODY4 | 606392 | PDX1 | IPF1 | 600733 | SEQ, MLPA, NGS | M | Meta |
Maturity-onset diabetes of the young, type 5 | MODY5 | 137920 | HNF1B | TCF2 | 189907 | SEQ, MLPA, NGS | M | Meta |
McLeod syndrome | MCLDS | 300842 | XK | 314850 | SEQ, NGS | M | Neuro | |
Medullary cystic kidney disease 2 | MCKD2 | 603860 | UMOD | 191845 | SEQ, NGS | M | Meta | |
Medulloblastoma, desmoplastic | 155255 | SUFU | 607035 | SEQ, MLPA, NGS | M | Tumor | ||
Melanoma-pancreatic cancer syndrome, familial | MPCS, Familial atypical multiple mole melanoma-pancreatic carcinoma syndrome FAMMM-PC | 606719 | CDK4 exon 2 | 123829 | SEQ | M | Tumor | |
Melanoma-pancreatic cancer syndrome, familial | MPCS, Familial atypical multiple mole melanoma-pancreatic carcinoma syndrome FAMMM-PC | 606719 | CDKN2A | 600160 | SEQ, MLPA, NGS | M | Tumor | |
Mental retardation, aphasia, shuffling gait, and adducted thumbs | MASA syndrome | 303350 | L1CAM | 308840 | SEQ, MLPA, NGS | M | Syndro | |
Mental retardation, X-linked 19 | MRX19 | 300844 | RPS6KA3 | 300075 | SEQ, MLPA, NGS | M | Syndro | |
Mental retardation, X-linked syndromic, Lubs type | MRXSL | 300260 | MECP2 | 300005 | SEQ, MLPA, NGS | M | Syndro | |
Mental retardation, X-linked, syndromic 13 | MRX13 | 300055 | MECP2 | 300005 | SEQ, MLPA, NGS | M | Syndro | |
Metachondromatosis | 156250 | PTPN11 | 176876 | SEQ, NGS | M | Tissue | ||
Metachromatic leukodystrophy | Arylsulfatase A deficiency, diffuse cerebral sclerosis | 250100 | ARSA | 607574 | SEQ, NGS | M | Meta | |
Metachromatic leukodystrophy due to saposin B deficiency | Saposin B deficiency | 249900 | PSAP | 176801 | SEQ, NGS | M | Meta | |
Metaphyseal chondrodysplasia, Murk Jansen type | 156400 | PTH1R | 168468 | SEQ, NGS | M | Tissue | ||
Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly | MDMHB | 156510 | RUNX2 | 600211 | SEQ, MLPA, NGS | M | Tissue | |
Metatropic dysplasia | Metatropic dwarfism | 156530 | TRPV4 | 605427 | SEQ, NGS | M | Tissue | |
Methemoglobinemia type 4 | 250790 | CYB5A | 613218 | SEQ, NGS | M | Coagul | ||
Methemoglobinemia, type 1 and 2 | Methemoglobinemia due to deficiency of methemoglobin reductase | 250800 | CYB5R3 | 613213 | SEQ, NGS | M | Coagul | |
Methionine adenosyltransferase deficiency | Hypermethioninemia | 250850 | MAT1A | 610550 | SEQ, NGS | M | Meta | |
Methylenetetrahydrofolate reductase deficiency | Homocystinuria due to MTHFR deficiency | 236250 | MTHFR | 607093 | SEQ, NGS | M | Meta | |
Mevalonic aciduria | MEVA | 610377 | MVK | 251170 | SEQ, NGS | M | Meta | |
Microcephaly and chorioretinopathy, autosomal recessive | 251270 | TUBGCP6 | 610053 | SEQ, NGS | M | Syndro | ||
Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation | MCLMR | 152950 | KIF11 | 148760 | SEQ, NGS | M | Syndro | |
Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma | MRCS | 193220 | BEST1 | 607854 | SEQ, MLPA, NGS | M | Sensory | |
Microphthalmia with coloboma 6 | MCOPCB6 | 613703 | GDF3 | 606522 | SEQ, NGS | M | Syndro | |
Microphthalmia, isolated 4 | MCOP4 | 613094 | GDF6 | 601147 | SEQ, NGS | M | Syndro | |
Microphthalmia, isolated 7 | MCOP7 | 613704 | GDF3 | 606522 | SEQ, NGS | M | Syndro | |
Microphthalmia, syndromic | MCOPS3, optic nerve hypoplasia and abnormalities of the central nervous system | 206900 | SOX2 | 184429 | SEQ, MLPA, NGS | M | Syndro | |
Miller-Dieker lissencephaly syndrome | MDLS | 247200 | del17p13.3 (LIS1 gene) | MLPA | M | Micro | ||
Mitochondrial complex II deficiency | 252011 | SDHA | 600857 | SEQ, MLPA, NGS | M | Neuro | ||
Mitochondrial DNA depletion syndrome type 1 | MNGIE, Mitochondrial neurogastrointestinal encephalopathy syndrome, MTDPS1 | 603041 | TYMP | ECGF1 | 131222 | SEQ, NGS | M | Neuro |
Mitochondrial DNA depletion syndrome type 12, cardiomyopathic type | MTDPS12 | 615418 | SLC25A4 | 103220 | SEQ, MLPA, NGS | M | Neuro | |
Mitochondrial DNA depletion syndrome type 4A | MTDPS4A, Alpers syndrome | 203700 | POLG | POLG1 | 174763 | SEQ, MLPA, NGS | M | Neuro |
Mitochondrial DNA depletion syndrome type 4B | MTDPS4B, Mitochondrial neurogastrointestinal encephalopathy syndrome, MNGIE | 613662 | POLG | POLG1 | 174763 | SEQ, MLPA, NGS | M | Neuro |
Mitochondrial DNA depletion syndrome type 5 | MTDPS5 | 612073 | SUCLA2 | 603921 | SEQ, MLPA, NGS | M | Neuro | |
Mitochondrial DNA depletion syndrome type 7, hepatocerebral type | MTDPS7 | 271245 | TWNK | C10ORF2, TWINKLE | 606075 | SEQ, MLPA, NGS | M | Neuro |
Mitochondrial DNA depletion syndrome type 8A | MTDPS8A | 612075 | RRM2B | 604712 | SEQ, MLPA, NGS | M | Neuro | |
Mitochondrial DNA depletion syndrome type 8B | MNGIE , mitochondrial neurogastrointestinal encephalopathy syndrome, MTDPS8B | 612075 | RRM2B | 604712 | SEQ, MLPA, NGS | M | Neuro | |
Mitochondrial DNA depletion syndrome type 9 | MTDPS9 | 245400 | SUCLG1 | 611224 | SEQ, MLPA, NGS | M | Neuro | |
Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes | MELAS | 540000 | MT-ND1 | 516000 | SEQ, NGS | M | Neuro | |
Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes | MELAS | 540000 | MT-ND5 | 516005 | SEQ, NGS | M | Neuro | |
Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes | MELAS | 540000 | MT-ND6 | 516006 | SEQ, NGS | M | Neuro | |
Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes | MELAS | 540000 | MT-TH | 590040 | SEQ, NGS | M | Neuro | |
Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes | MELAS | 540000 | MT-TK | 590060 | SEQ, NGS | M | Neuro | |
Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes | MELAS | 540000 | MT-TL1 | 590050 | SEQ, NGS | M | Neuro | |
Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes | MELAS | 540000 | MT-TS2 | 590085 | SEQ, NGS | M | Neuro | |
Mitochondrial trifunctional protein deficiency | MTPD | 609015 | HADHA | 600890 | SEQ, NGS | M | Meta | |
Miyoshi muscular dystrophy 1 | MMD1 | 254130 | DYSF | 603009 | SEQ, MLPA, NGS | M | Neuro | |
Miyoshi muscular dystrophy 3 | MMD3 | 613319 | ANO5 | 608662 | SEQ, MLPA, NGS | M | Neuro | |
Muckle-Wells syndrome | MWS, cryopyrin-associated periodic syndrome 2, CAPS2 | 191900 | NLRP3 | 606416 | SEQ, NGS | M | Fever | |
Mucopolysaccharidosis type IH, Hurler syndrome | MPS1-H | 607014 | IDUA | 252800 | SEQ, NGS | M | Meta | |
Mucopolysaccharidosis type IH/S, Hurler-Scheie syndrome | MPS1-H/S | 607015 | IDUA | 252800 | SEQ, NGS | M | Meta | |
Mucopolysaccharidosis type IIIB, Sanfilippo syndrome B | MPS IIIB | 252920 | NAGLU | 609701 | SEQ, NGS | M | Meta | |
Mucopolysaccharidosis type IIIC, Sanfilippo syndrome C | MPS IIIC | 252930 | HGSNAT | 610453 | SEQ, NGS | M | Meta | |
Mucopolysaccharidosis type IIID, Sanfilippo syndrome D | MPS IIID | 252940 | GNS | 607664 | SEQ, NGS | M | Meta | |
Mucopolysaccharidosis type IS, Scheie syndrome | MPS1-S | 607016 | IDUA | 252800 | SEQ, NGS | M | Meta | |
Muenke syndrome | MNKES | 602849 | FGFR3 mutation p.Pro250Arg | 134934 | SEQ | M | Syndro | |
Multiple endocrine neoplasia type 1 | MEN1 | 131100 | MEN1 | 613733 | SEQ, MLPA, NGS | M | Tumor | |
Multiple endocrine neoplasia type 2 A | MEN2A | 171400 | RET | 164761 | SEQ, MLPA, NGS | M | Tumor | |
Multiple endocrine neoplasia type 2 B | MEN2B | 162300 | RET | 164761 | SEQ, MLPA, NGS | M | Tumor | |
Multiple endocrine neoplasia type 4 | MEN4 | 610755 | CDKN1B | 600778 | SEQ, MLPA, NGS | M | Tumor | |
Multiple system atrophy | MSA | 146500 | SNCA rs11931074 | 163890 | SEQ | M | Neuro | |
Muscular dystrophy, congenital, 1C | MDC1C | 606612 | FKRP | 606596 | SEQ, MLPA, NGS | M | Neuro | |
Muscular dystrophy, limb-girdle, type 1B | LGMD1B | 159001 | LMNA | 150330 | SEQ, MLPA, NGS | M | Neuro | |
Muscular dystrophy, limb-girdle, type 1C | LGMD1C | 607801 | CAV3 | 601253 | SEQ, MLPA, NGS | M | Neuro | |
Muscular dystrophy, limb-girdle, type 2A | LGMD2A | 253600 | CAPN3 | 114240 | SEQ, MLPA, NGS | M | Neuro | |
Muscular dystrophy, limb-girdle, type 2B | LGMD2B | 253601 | DYSF | 603009 | SEQ, MLPA, NGS | M | Neuro | |
Muscular dystrophy, limb-girdle, type 2I | LGMD2I | 607155 | FKRP | 606596 | SEQ, MLPA, NGS | M | Neuro | |
Muscular dystrophy, limb-girdle, type 2L | LGMD2L | 611307 | ANO5 | 608662 | SEQ, MLPA, NGS | M | Neuro | |
MUTYH-associated polyposis | MAP | 608456 | MUTYH | 604933 | SEQ, MLPA, NGS | M | Tumor | |
Myoclonic epilepsy associated with ragged-red fibers | MERRF | 545000 | MT-ND5 | 516005 | SEQ, NGS | M | Neuro | |
Myoclonic epilepsy associated with ragged-red fibers | MERRF | 545000 | MT-TH | 590040 | SEQ, NGS | M | Neuro | |
Myoclonic epilepsy associated with ragged-red fibers | MERRF | 545000 | MT-TK | 590060 | SEQ, NGS | M | Neuro | |
Myoclonic epilepsy associated with ragged-red fibers | MERRF | 545000 | MT-TL1 | 590050 | SEQ, NGS | M | Neuro | |
Myoclonic epilepsy associated with ragged-red fibers | MERRF | 545000 | MT-TS2 | 590085 | SEQ, NGS | M | Neuro | |
Myofibromatose, infantile, type 1 | IMF1 | 228550 | PDGFRB | 173410 | SEQ, NGS | M | Neuro | |
Myofibromatose, infantile, type 2 | IMF2 | 615293 | NOTCH3 | 600276 | SEQ, MLPA, NGS | M | Neuro | |
Myopathy, distal, Tateyama type | MPDT | 614321 | CAV3 | 601253 | SEQ, MLPA, NGS | M | Neuro | |
Myotonia congenita Becker, autosomal recessive | 255700 | CLCN1 | 118425 | SEQ, MLPA, NGS | M | Neuro | ||
Myotonia congenita Thomsen, autosomal dominant | 160800 | CLCN1 | 118425 | SEQ, MLPA, NGS | M | Neuro | ||
Myotonia congenita, acetazolamide-responsive | sodium channel myotonia | 608390 | SCN4A | 603967 | SEQ, MLPA, NGS | M | Neuro | |
Myotubular myopathy/ centronuclear myopathy, autosomal dominant | CNM1 | 160150 | DNM2 | 602378 | SEQ, NGS | M | Neuro | |
Myotubular myopathy/ centronuclear myopathy, X-chromosomal-recessive | CNMX | 310400 | MTM1 | 300415 | SEQ, NGS | M | Neuro | |
N-acetylglutamate synthase deficiency | NAGS deficiency | 237310 | NAGS | 608300 | SEQ, NGS | N | Meta | |
N-acetylglutamate synthase deficiency | NAGS deficiency | 237310 | NAGS | 608300 | SEQ, NGS | N | Path | |
Nail-patella syndrome | NPS, Turner-Kieser syndrome, Fong disease | 161200 | LMX1B | NPS1 | 602575 | SEQ, MLPA, NGS | N | Syndro |
Narcolepsy type 1 | NRCLP1 | 161400 | HCRT | 602358 | SEQ, NGS | N | Neuro | |
Narcolepsy type 5 | NRCLP5 | 612851 | TRA rs1154155 | TRA@, T-cell receptor alpha, TCRA | 186880 | SEQ | N | Neuro |
Narcolepsy type 7 | NRCLP7 | 614250 | MOG | 159465 | SEQ, NGS | N | Neuro | |
Narcolepsy, association | 161400 | HLA-DQB1*0602 allele | 604305 | SEQ | N | Neuro | ||
NARP | Neuropathy, Ataxia, retinitis pigmentosa | 551500 | MT-ATP6 | 516060 | SEQ, NGS | N | Neuro | |
Neurodegeneration with brain iron accumulation, type 1 | NBIA1, formerly Hallervorden-Spatz disease | 234200 | PANK2 | 606157 | SEQ, MLPA, NGS | N | Neuro | |
Neurodegeneration with brain iron accumulation, type 2A | NBIA2A, infantile neuroaxonal dystrophy | 256600 | PLA2G6 | 603604 | SEQ, MLPA, NGS | N | Neuro | |
Neurodegeneration with brain iron accumulation, type 2B | NBIA2B | 610217 | PLA2G6 | 603604 | SEQ, MLPA, NGS | N | Neuro | |
Neurodegeneration with brain iron accumulation, type 3 | NBIA3 | 606159 | FTL | 134790 | SEQ, NGS | N | Neuro | |
Neurodegeneration with brain iron accumulation, type 5 | NBIA5 | 300894 | WDR45 | 300526 | SEQ, NGS | N | Neuro | |
Neurofibromatosis type 1 | NF1 | 162200 | NF1 | 613113 | SEQ, MLPA, NGS | N | Tumor | |
Neurofibromatosis type 1-like syndrome | Legius syndrome | 611431 | SPRED1 | 609291 | SEQ, MLPA, NGS | N | Tumor | |
Neurofibromatosis type 2 | NF2 | 101000 | NF2 | 607379 | SEQ, MLPA, NGS | N | Tumor | |
Neuropathy with giant axonal swelling, type 1 | Giant Axonal Neuropathy 1, GAN1 | 256850 | GAN | 605379 | SEQ, NGS | N | Neuro | |
Neuropathy, distal hereditary motor, type IIA | HMN2A | 158590 | HSPB8 | 608014 | SEQ, MLPA, NGS | N | Neuro | |
Neuropathy, distal hereditary motor, type IIB | HMN2B | 608634 | HSPB1 | 602195 | SEQ, MLPA, NGS | N | Neuro | |
Neuropathy, distal hereditary motor, type VA | HMN5A | 600794 | BSCL2 | 606158 | SEQ, NGS | N | Neuro | |
Niemann-Pick disease, type A | 257200 | SMPD1 | 607608 | SEQ, MLPA, NGS | N | Meta | ||
Niemann-Pick disease, type B | 607616 | SMPD1 | 607608 | SEQ, MLPA, NGS | N | Meta | ||
Niemann-Pick disease, type C1 | NPC1 | 257220 | NPC1 | 607623 | SEQ, MLPA, NGS | N | Meta | |
Niemann-Pick disease, type C2 | NPC2 | 607625 | NPC2 | 601015 | SEQ, MLPA, NGS | N | Meta | |
Nijmegen breakage syndrome | NBS | 251260 | NBN | NBS1 | 602667 | SEQ, NGS | N | Tumor |
Nonautoimmune hyperthyroidism | 609152 | TSHR | 603372 | SEQ, MLPA, NGS | N | Meta | ||
Noonan syndrome 1 | NS1 | 163950 | PTPN11 | 176876 | SEQ, NGS | N | Syndro | |
Noonan syndrome 3 | NS3 | 609942 | KRAS | 190070 | SEQ, NGS | N | Syndro | |
Noonan syndrome 4 | NS4 | 610733 | SOS1 | 182530 | SEQ, NGS | N | Syndro | |
Noonan syndrome 5 | NS5 | 611553 | RAF1 | 164760 | SEQ, NGS | N | Syndro | |
Noonan syndrome 6 | NS6 | 613224 | NRAS | NRAS1 | 64790 | SEQ, NGS | N | Syndro |
Noonan syndrome 7 | NS7 | 613706 | BRAF | 164757 | SEQ, NGS | N | Syndro | |
Noonan syndrome 8 | NS8 | 615355 | RIT1 | 609591 | SEQ, NGS | N | Syndro | |
Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia | NSLL, CBL syndrome | 613563 | CBL | 165360 | SEQ, NGS | N | Syndro | |
Noonan syndrome-like with loose anagen hair | 607721 | SHOC2 | 602775 | SEQ, NGS | N | Syndro | ||
Obesity | 601665 | MC4R | 155541 | SEQ, MLPA, NGS | O | Meta | ||
Obesity | SIM1 | 603128 | SEQ, MLPA, NGS | O | Meta | |||
Obesity, early-onset, with adrenal insufficiency and red hair | OBAIRH | 609734 | POMC | 176830 | SEQ, MLPA, NGS | O | Meta | |
Obesity, morbid, due to leptin deficiency | 614962 | LEP | 164160 | SEQ, MLPA, NGS | O | Meta | ||
Obesity, morbid, due to leptin receptor deficiency | 614963 | LEPR | 601007 | SEQ, MLPA, NGS | O | Meta | ||
Ocular albinism, type 1 | OA1, Nettleship-Falls type | 300500 | GPR143 | OA1 gene | 300808 | SEQ, MLPA, NGS | O | Meta |
Oculopharyngeal muscular dystrophy | OPMD | 164300 | PABPN1 repeat | 602279 | REP | O | Neuro | |
Odontohypophosphatasia | HPPO | 146300 | ALPL | 171760 | SEQ, MLPA, NGS | O | Meta | |
Odontoonychodermal dysplasia | OODD | 257980 | WNT10A | 606268 | SEQ, MLPA, NGS | O | Syndro | |
Oligodontia-colorectal cancer syndrome | ODCRCS | 608615 | AXIN2 | 604025 | SEQ, NGS | O | Syndro | |
Oliver-McFarlane syndrome | OMCS | 275400 | PNPLA6 | 603197 | SEQ, NGS | O | Neuro | |
Optic atrophy | Kjer type, OPA1 | 165500 | OPA1 | 605290 | SEQ, MLPA, NGS | O | Sensory | |
Optic atrophy-7 with or without auditory neuropathy | OPA7 | TMEM126A | 612988 | SEQ, NGS | O | Sensory | ||
Optic nerve hypoplasia, bilateral | Optic nerve aplasia, bilateral | 165550 | PAX6 | 607108 | SEQ, MLPA, NGS | O | Sensory | |
Ornithine transcarbamylase deficiency | Hyperammonemia due to OTC deficiency | 311250 | OTC | 300461 | SEQ, MLPA, NGS | O | Meta | |
Ornithine transcarbamylase deficiency | Hyperammonemia due to OTC deficiency | 311250 | OTC | 300461 | SEQ, MLPA, NGS | O | Path | |
Orofacial cleft type 5 | 608874 | MSX1 | 142983 | SEQ, NGS | O | Syndro | ||
Orofaciodigital syndrome type 1 | OFD I | 311200 | CXORF5 | 300170 | SEQ, NGS | O | Syndro | |
Osseous heteroplasia, progressive | POH | 166350 | GNAS | 139320 | SEQ, MLPA, NGS | O | Tissue | |
Osteogenesis imperfecta, type I | OI1 | 166200 | COL1A1 | 120150 | SEQ, MLPA, NGS | O | Tissue | |
Osteogenesis imperfecta, type II | OI2 | 166210 | COL1A1 | 120150 | SEQ, MLPA, NGS | O | Tissue | |
Osteogenesis imperfecta, type II | OI2 | 166210 | COL1A2 | 120160 | SEQ, MLPA, NGS | O | Tissue | |
Osteogenesis imperfecta, type III | OI3 | 259420 | COL1A1 | 120150 | SEQ, MLPA, NGS | O | Tissue | |
Osteogenesis imperfecta, type III | OI3 | 259420 | COL1A2 | 120160 | SEQ, MLPA, NGS | O | Tissue | |
Osteogenesis imperfecta, type IV | OI4 | 166220 | COL1A1 | 120150 | SEQ, MLPA, NGS | O | Tissue | |
Osteogenesis imperfecta, type IV | OI4 | 166220 | COL1A2 | 120160 | SEQ, MLPA, NGS | O | Tissue | |
Osteogenesis imperfecta, type XI | OI11 | 610968 | FKBP10 | FK506 | 607063 | SEQ, NGS | O | Tissue |
Otospondylomegaepiphyseal dysplasia, autosomal dominant | OSMEDA, Weissenbacher-Zweymuller syndrome, WZS, formerly: Stickler syndrome type 3, STL3 | 184840 | COL11A2 | 120290 | SEQ, NGS | O | Syndro | |
Otospondylomegaepiphyseal dysplasia, autosomal recessive | OSMED | 215150 | COL11A2 | 120290 | SEQ, NGS | O | Tissue | |
Ovarioleukodystrophy | Vanishing white matter leukodystrophy with ovarian failure | 603896 | EIF2B2 | 606454 | SEQ, NGS | O | Neuro | |
Ovarioleukodystrophy | Vanishing white matter leukodystrophy with ovarian failure | 603896 | EIF2B5 | 603945 | SEQ, NGS | O | Neuro | |
Paget disease of bone | PDB3 | 602080 | SQSTM1 | 601530 | SEQ, NGS | P | Tissue | |
Pallister-Hall syndrome | hypothalamic hamartoblastoma, hypopituitarism, imperforate anus, and postaxial polydactyly | 146510 | GLI3 | 165240 | SEQ, NGS | P | Syndro | |
Pancreatic cancer, susceptibility, type 1 | PNCA1 | 606856 | PALLD | 608092 | SEQ, NGS | P | Tumor | |
Pancreatic cancer, susceptibility, type 2 | PNCA2 | 613347 | BRCA2 | 600185 | SEQ, MLPA, NGS | P | Tumor | |
Pancreatic cancer, susceptibility, type 3 | PNCA3 | 613348 | PALB2 | 610355 | SEQ, MLPA, NGS | P | Tumor | |
Pancreatic cancer, susceptibility, type 4 | PNCA4 | 614320 | BRCA1 | 113705 | SEQ, MLPA, NGS | P | Tumor | |
Paragangliomas, familial, type 1 | PGL1 | 168000 | SDHD | 602690 | SEQ, MLPA, NGS | P | Tumor | |
Paragangliomas, familial, type 2 | PGL2 | 601650 | SDHAF2 | SDH5 | 613019 | SEQ, MLPA, NGS | P | Tumor |
Paragangliomas, familial, type 3 | PGL3 | 605373 | SDHC | 602413 | SEQ, MLPA, NGS | P | Tumor | |
Paragangliomas, familial, type 4 | PGL4 | 115310 | SDHB | 185470 | SEQ, MLPA, NGS | P | Tumor | |
Paragangliomas, familial, type 5 | PGL5 | 614165 | SDHA | 600857 | SEQ, MLPA, NGS | P | Tumor | |
Paramyotonia congenita of von Eulenburg | PMC | 168300 | SCN4A | 603967 | SEQ, MLPA, NGS | P | Neuro | |
Parastremmatic dwarfism | 168400 | TRPV4 | 605427 | SEQ, NGS | P | Tissue | ||
Parkinson disease, autosomal dominant, type 1 | PARK1, Lewy Body Parkinson disease | 168601 | SNCA | 163890 | SEQ, MLPA, NGS | P | Neuro | |
Parkinson disease, autosomal dominant, type 4 | PARK4, Lewy Body Parkinson disease | 605543 | SNCA | 163890 | SEQ, MLPA, NGS | P | Neuro | |
Parkinson disease, autosomal dominant, type 5 | PARK5 | 613643 | UCHL1 | 191342 | SEQ, MLPA, NGS | P | Neuro | |
Parkinson disease, autosomal dominant, type 8 | PARK8 | 607060 | LRRK2 | 609007 | SEQ, MLPA, NGS | P | Neuro | |
Parkinson disease, autosomal recessive, adult-onset, type 14 | PARK14, Dystonia-parkinsonismus | 612953 | PLA2G6 | 603604 | SEQ, MLPA, NGS | P | Neuro | |
Parkinson disease, autosomal recessive, early-onset, type 6 | PARK6 | 605909 | PINK1 | 608309 | SEQ, MLPA, NGS | P | Neuro | |
Parkinson disease, autosomal recessive, early-onset, type 7 | PARK7 | 606324 | PARK7 | DJ1 | 602533 | SEQ, MLPA, NGS | P | Neuro |
Parkinson disease, autosomal recessive, juvenile, type 2 | PARK2 | 600116 | PARK2 | PRKN | 602544 | SEQ, MLPA, NGS | P | Neuro |
Paroxysmal extreme pain disorder | PEXPD or PEPD | 167400 | SCN9A | 603415 | SEQ, NGS | P | Neuro | |
Paroxysmal kinesigenic dyskinesia | PKD, Dystonie 10 | 128200 | PRRT2 | 614386 | SEQ, MLPA, NGS | P | Neuro | |
Partial deficiency of complement component 4 | 120790 | SERPING1 | 606860 | SEQ, MLPA, NGS | P | Coagul | ||
Patterned dystrophy of retinal pigment epithelium, butterfly shaped | MDPT1 | 169150 | PRPH2 | 179605 | SEQ, MLPA, NGS | P | Sensory | |
Periodic fever, menstrual cycle-dependent | PMFC | 614674 | HTR1A promoter mutation -480delA | 109760 | SEQ | P | Fever | |
Perthes disease | Legg-Calve-Perthes disease | 150600 | COL2A1 | 120140 | SEQ, MLPA, NGS | P | Tissue | |
Peutz-Jeghers syndrome | PJS | 175200 | STK11 | 602216 | SEQ, MLPA, NGS | P | Tumor | |
Pfeiffer syndrome | FGFR1 136350 p.Pro252Arg | 101600 | FGFR1 p.Pro252Arg | 136350 | SEQ | P | Syndro | |
Pfeiffer syndrome | 101600 | FGFR2 | 176943 | SEQ, MLPA, NGS | P | Syndro | ||
Phenylketonuria | PKU, hyperphenylalaninemia | 261600 | PAH | 612349 | SEQ, MLPA, NGS | P | Meta | |
Pheochromocytoma | PCC | 171300 | MAX | 154950 | SEQ, MLPA, NGS | P | Kidney | |
Pheochromocytoma | PCC | 171300 | MAX | 154950 | SEQ, MLPA, NGS | P | Tumor | |
Pheochromocytoma | PCC | 171300 | RET | 164761 | SEQ, MLPA, NGS | P | Kidney | |
Pheochromocytoma | PCC | 171300 | RET | 164761 | SEQ, MLPA, NGS | P | Tumor | |
Pheochromocytoma | PCC | 171300 | SDHB | 185470 | SEQ, MLPA, NGS | P | Kidney | |
Pheochromocytoma | PCC | 171300 | SDHB | 185470 | SEQ, MLPA, NGS | P | Tumor | |
Pheochromocytoma | PCC | 171300 | SDHC | 602413 | SEQ, MLPA, NGS | P | Kidney | |
Pheochromocytoma | PCC | 171300 | SDHC | 602413 | SEQ, MLPA, NGS | P | Tumor | |
Pheochromocytoma | PCC | 171300 | SDHD | 602690 | SEQ, MLPA, NGS | P | Kidney | |
Pheochromocytoma | PCC | 171300 | SDHD | 602690 | SEQ, MLPA, NGS | P | Tumor | |
Pheochromocytoma | PCC | 171300 | TMEM127 | 613403 | SEQ, NGS | P | Kidney | |
Pheochromocytoma | PCC | 171300 | TMEM127 | 613403 | SEQ, NGS | P | Tumor | |
Pheochromocytoma | PCC | 171300 | VHL | 608537 | SEQ, MLPA, NGS | P | Kidney | |
Pheochromocytoma | PCC | 171300 | VHL | 608537 | SEQ, MLPA, NGS | P | Tumor | |
Pheochromocytoma / Paraganglioma syndromes, familial | PCC/PGL | MAX | 154950 | SEQ, MLPA, NGS | P | Tumor | ||
Pheochromocytoma / Paraganglioma syndromes, familial | PCC/PGL | MAX | 154950 | SEQ, MLPA, NGS | P | Kidney | ||
Pheochromocytoma / Paraganglioma syndromes, familial | PCC/PGL | SDHAF2 | SDH5 | 613019 | SEQ, MLPA, NGS | P | Tumor | |
Pheochromocytoma / Paraganglioma syndromes, familial | PCC/PGL | SDHAF2 | SDH5 | 613019 | SEQ, MLPA, NGS | P | Tumor | |
Pheochromocytoma / Paraganglioma syndromes, familial | PCC/PGL | SDHB | 185470 | SEQ, MLPA, NGS | P | Kidney | ||
Pheochromocytoma / Paraganglioma syndromes, familial | PCC/PGL | SDHB | 185470 | SEQ, MLPA, NGS | P | Kidney | ||
Pheochromocytoma / Paraganglioma syndromes, familial | PCC/PGL | SDHC | 602413 | SEQ, MLPA, NGS | P | Tumor | ||
Pheochromocytoma / Paraganglioma syndromes, familial | PCC/PGL | SDHC | 602413 | SEQ, MLPA, NGS | P | Tumor | ||
Pheochromocytoma / Paraganglioma syndromes, familial | PCC/PGL | SDHD | 602690 | SEQ, MLPA, NGS | P | Kidney | ||
Pheochromocytoma / Paraganglioma syndromes, familial | PCC/PGL | SDHD | 602690 | SEQ, MLPA, NGS | P | Kidney | ||
Pheochromocytoma / Paraganglioma syndromes, familial | PCC/PGL | TMEM127 | 613403 | SEQ, NGS | P | Kidney | ||
Pheochromocytoma / Paraganglioma syndromes, familial | PCC/PGL | TMEM127 | 613403 | SEQ, NGS | P | Tumor | ||
Phosphoribosylpyrophosphate synthetase superactivity | PRPS-related Gout, hyperuricemia | 300661 | PRPS1 | 311850 | SEQ, NGS | P | Meta | |
Pick disease of brain | Dementia with lobar atrophy and neuronal cytoplasmic inclusions | 172700 | MAPT | 157140 | SEQ, MLPA, NGS | P | Neuro | |
Pick disease of brain | Dementia with lobar atrophy and neuronal cytoplasmic inclusions | 172700 | PSEN1 | 104311 | SEQ, MLPA, NGS | P | Neuro | |
Pigmented nodular adrenocortical disease, primary, 1 | PPNAD1 | 610489 | PRKAR1A | 188830 | SEQ, MLPA, NGS | P | Tumor | |
Pigmented nodular adrenocortical disease, primary, 1 | PPNAD1 | 610489 | PRKAR1A | 188830 | SEQ, MLPA, NGS | P | Kidney | |
Polycystic kidney disease 1 | PKD1 | 173900 | PKD1 | 601313 | SEQ, MLPA, NGS | P | Kidney | |
Polycystic kidney disease 2 | PKD2 | 613095 | PKD2 | 173910 | SEQ, MLPA, NGS | P | Kidney | |
Polycystic kidney disease type 1 | PKD1 | 173900 | PKD1 | 601313 | SEQ, MLPA, NGS | P | Syndro | |
Polycystic kidney disease type 2 | PKD2 | 613095 | PKD2 | 173910 | SEQ, MLPA, NGS | P | Syndro | |
Polycystic kidney disease type 3 | PKD3 | 600666 | GANAB | 104160 | SEQ, NGS | P | Kidney | |
Polycystic kidney disease type 3 | PKD3 | 600666 | GANAB | 104160 | SEQ, NGS | P | Syndro | |
Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy-2 | PLOSL2 | 618193 | TREM2 | 605086 | SEQ, NGS | P | Neuro | |
Polycystic liver disease 1 | PCLD1 | 174050 | PRKCSH | 177060 | SEQ, NGS | P | Syndro | |
Polycystic liver disease 2 | PCLD2 | 174050 | SEC63 | 608648 | SEQ, NGS | P | Syndro | |
Pontocerebellar hypoplasia type 2A | PCH2A | 277470 | TSEN54 | 608755 | SEQ, NGS | P | Neuro | |
Pontocerebellar hypoplasia type 2B | PCH2B | 612389 | TSEN2 | 608753 | SEQ, NGS | P | Neuro | |
Pontocerebellar hypoplasia type 2C | PCH2C | 612390 | TSEN34 | 608754 | SEQ, NGS | P | Neuro | |
Pontocerebellar hypoplasia type 4 | PCH4 | 225753 | TSEN54 | 608755 | SEQ, NGS | P | Neuro | |
Popliteal pterygium syndrome | PPS | 119500 | IRF6 | 607199 | SEQ, MLPA, NGS | P | Syndro | |
Porencephaly type 1 | POREN1, Brain Small Vessel Disease | 175780 | COL4A1 | 120130 | SEQ, NGS | P | Neuro | |
Porencephaly type 2 | POREN2, Brain Small Vessel Disease | 2614483 | COL4A2 | 120090 | SEQ, NGS | P | Neuro | |
Porokeratosis type 3, actinic disseminated superficial | POROK3 | 175900 | MVK | 251170 | SEQ, NGS | P | Geno | |
Porphyria cutanea tarda | Uroporphyrinogen decarboxylase deficiency | 176100 | UROD | 613521 | SEQ, MLPA, NGS | P | Meta | |
Porphyria, acute intermittent | AIP | 176000 | HMBS | 609806 | SEQ, MLPA, NGS | P | Meta | |
Porphyria, acute intermittent, nonerythroid variant | AIP | 176000 | HMBS | 609806 | SEQ, MLPA, NGS | P | Meta | |
Postaxial polydactyly type A1 and type B | PAPA1 (PAPB included) | 174200 | GLI3 | 165240 | SEQ, NGS | P | Syndro | |
Potocki-Lupski syndrome | PTLS | 610883 | Dup17p11.2 (RAI1 gene) | 607642 | MLPA | P | Micro | |
Preaxial polydactyly type IV | Polysyndactyly, uncomplicated | 174700 | GLI3 | 165240 | SEQ, NGS | P | Syndro | |
Precocious puberty, central, | CPPB1 | 176400 | KISS1R | 604161 | SEQ, MLPA, NGS | P | Syndro | |
Premature ovarian failure 7 | POF7 | 612964 | NR5A1 | 184757 | SEQ, MLPA, NGS | P | Syndro | |
Premature ovarian failure type 3 | POF3 | 608996 | FOXL2 | 605597 | SEQ, MLPA, NGS | P | Syndro | |
Premature ovarian failure type 4 | POF4 | 300510 | BMP15 | 300247 | SEQ, NGS | P | Syndro | |
Primary lateral sclerosis, juvenile | PLSJ | 606353 | ALS2 | 606352 | SEQ, NGS | P | Neuro | |
Prion disease with protracted course | 606688 | PRNP | 176640 | SEQ, NGS | P | Neuro | ||
Progressive external ophthalmoplegia autosomal recessive 1 | PEOB1, chronic progressive external ophthalmoplegia type 1, CPEO1 | 258450 | POLG | POLG1 | 174763 | SEQ, MLPA, NGS | C | Neuro |
Progressive external ophthalmoplegia autosomal dominant 1 | PEOA1, chronic progressive external ophthalmoplegia type 1, CPEO1 | 157640 | POLG | POLG1 | 174763 | SEQ, MLPA, NGS | C | Neuro |
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, type 3 | 609286 | TWNK | C10orf2, TWINKLE | 606075 | SEQ, MLPA, NGS | P | Neuro | |
Protein C deficiency, autosomal dominant | THPH3 | 176860 | PROC | 612283 | SEQ, MLPA, NGS | P | Coagul | |
Protein C deficiency, autosomal recessive | THPH4 | 612304 | PROC | 612283 | SEQ, MLPA, NGS | P | Coagul | |
Protein S deficiency, autosomal dominant | THPH5 | 612336 | PROS1 | 176880 | SEQ, MLPA, NGS | P | Coagul | |
Protein S deficiency, autosomal recessive | THPH6 | 614514 | PROS1 | 176880 | SEQ, MLPA, NGS | P | Coagul | |
Protoporphyria, erythropoietic, X-linked | XLEPP | 300752 | ALAS2 | 301300 | SEQ, NGS | P | Meta | |
Pseudohypoparathyroidism type 1A | PHP1A | 103580 | GNAS | 139320 | SEQ, MLPA, NGS | P | Meta | |
Pseudohypoparathyroidism type 1B | PHP1B | 603233 | GNAS | 139320 | SEQ, MLPA, NGS | P | Meta | |
Pseudohypoparathyroidism type 1C | PHP1C | 612462 | GNAS | 139320 | SEQ, MLPA, NGS | P | Meta | |
Pseudopseudohypoparathyroidism | PPHP | 612463 | GNAS | 139320 | SEQ, MLPA, NGS | P | Meta | |
PTEN hamartoma tumor syndrome | 158350 | PTEN | 601728 | SEQ, MLPA, NGS | P | Tumor | ||
Pulmonary hypertension, primary, 3 | PPH3 | 615343 | CAV1 | 601047 | SEQ, NGS | P | Cardio | |
Pyogenic sterile arthritis, pyoderma gangrenosum, and acne | PAPA syndrome | 604416 | PSTPIP1 | 606347 | SEQ, NGS | P | Tissue | |
Pyruvate kinase deficiency of erythrocyte | 266200 | PKLR | 609712 | SEQ, MLPA, NGS | P | Meta | ||
Raine syndrome | RNS, osteosclerotic bone dysplasia, lethal | 259775 | FAM20C | 611061 | SEQ, NGS | R | Syndro | |
Raine syndrome | RNS, osteosclerotic bone dysplasia, lethal | 259775 | FAM20C | 611061 | SEQ, NGS | R | Tissue | |
Rapp-Hodgkin syndrome | ectodermal dysplasia, anhidrotic, with cleft lip/palate | 129400 | TP63 | p63, TP73L | 603273 | SEQ, NGS | R | Syndro |
Renal cell carcinoma, papillary, 1, familial and somatic | RCCP1 | 605074 | MET | 64860 | SEQ, NGS | R | Tumor | |
Renal cell carcinoma, papillary, 1, familial and somatic | RCCP1 | 605074 | MET1 | 64860 | SEQ, NGS | R | Kidney | |
Restless legs syndrome, periodic limb movements in sleep, type 6 | RLS6 | 611185 | BTBD9 rs3923809 | 611237 | SEQ | R | Neuro | |
Retinal cone dystrophy type 3A | RCD3A | 610024 | PDE6H | 601190 | SEQ, NGS | R | Sensory | |
Retinal cone dystrophy type 3B | RCD3B | 610356 | KCNV2 | 607604 | SEQ, NGS | R | Sensory | |
Retinitis pigmentosa 73 | RP73 | 616544 | HGSNAT | 610453 | SEQ, NGS | R | Sensory | |
Retinitis pigmentosa type 7, digenic included | RP7 | 608133 | PRPH2 | 179605 | SEQ, MLPA, NGS | R | Sensory | |
Retinitis punctata albescens | RPA | 136880 | PRPH2 | 179605 | SEQ, MLPA, NGS | R | Sensory | |
Retinoblastoma | RB | 180200 | RB1 | 614041 | SEQ, MLPA, NGS | R | Tumor | |
Retinoschisis 1, X-linked, juvenile | 312700 | RS1 | 300839 | SEQ, NGS | R | Sensory | ||
Rett syndrome | 312750 | MECP2 | 300005 | SEQ, MLPA, NGS | R | Syndro | ||
Rett syndrome, congenital variant | 613454 | FOXG1 | 164874 | SEQ, MLPA, NGS | R | Syndro | ||
Rippling muscle disease | RMD | 606072 | CAV3 | 601253 | SEQ, MLPA, NGS | R | Neuro | |
Robinow syndrome, autosomal dominant | 180700 | WNT5A | 164975 | SEQ, NGS | R | Syndro | ||
Saethre-Chotzen syndrome | SCS, acrocephalosyndactyly, type III | 101400 | TWIST1 | 601622 | SEQ, MLPA, NGS | S | Syndro | |
Saethre-Chotzen syndrome with eyelid anomalies | 101400 | TWIST1 | 601622 | SEQ, MLPA, NGS | S | Syndro | ||
Scapuloperoneal spinal muscular atrophy | SPSMA, New England type | 181405 | TRPV4 | 605427 | SEQ, NGS | S | Neuro | |
Schopf-Schulz-Passarge syndrome | SSPS, keratosis, palmoplantaris with cystic eyelids, hypodontia, and hypotrichosis | 606268 | WNT10A | 606268 | SEQ, MLPA, NGS | S | Syndro | |
Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis | SANDO, sensory ataxic neuropathy with mitochondrial DNA deletions, autosomal recessive | 607459 | POLG | POLG1 | 174763 | SEQ, MLPA, NGS | M | Neuro |
Sessile serrated polyposis cancer syndrome | SSPCS | 617108 | RNF43 | 612482 | SEQ, NGS | S | Neuro | |
Short QT syndrome 1 | SQT1 | 609620 | KCNH2 | 152427 | SEQ, MLPA, NGS | S | Cardio | |
Short QT syndrome 2 | SQT2 | 609621 | KCNQ1 | 607542 | SEQ, MLPA, NGS | S | Cardio | |
Short QT syndrome 3 | SQT3 | 609622 | KCNJ2 | 600681 | SEQ, MLPA, NGS | S | Cardio | |
Shprintzen-Goldberg syndrome | Shprintzen-Goldberg craniosynostosis syndrome | 182212 | SKI | 164780 | SEQ, NGS | S | Syndro | |
Shprintzen-Goldberg syndrome | Shprintzen-Goldberg Craniosynostosis syndrome | 182212 | SKI | 164780 | SEQ, NGS | S | Tissue | |
Sick sinus syndrome 1 | SSS1, autosomal recessive | 608567 | SCN5A | 600163 | SEQ, MLPA, NGS | S | Cardio | |
Sick sinus syndrome 2 | SSS2, autosomal dominant | 163800 | HCN4 | 605206 | SEQ, NGS | S | Cardio | |
Sickle cell anemia | HBS | 603903 | HBB | 141900 | SEQ, MLPA, NGS | S | Coagul | |
Sideroblastic Anemia 2, pyridoxine-refractory | 205950 | SLC25A38 | 610819 | SEQ, NGS | S | Coagul | ||
Sideroblastic Anemia, X-linked | SIDBA1 | 300751 | ALAS2 | 301300 | SEQ, NGS | S | Coagul | |
Simpson-Golabi-Behmel syndrome, type 2 | SGBS2 | 300209 | OFD1 | 300170 | SEQ, NGS | S | Syndro | |
Smith-Lemli-Opitz syndrome | SLOS | 270400 | DHCR7 | 602858 | SEQ, MLPA, NGS | S | Syndro | |
Smith-Magenis syndrome | 182290 | del17p11.2 (RAI1 gene) | 607642 | MLPA | S | Micro | ||
Smith-Magenis syndrome | 182290 | RAI1 (sequencing) | 607642 | SEQ, MLPA, NGS | S | Syndro | ||
Sorbitol dehydrogenase deficiency with peripheral neuropathy | SORDD | 618912 | SORD | 182500 | SEQ, NGS | S | Neuro | |
Sotos syndrome | cerebral gigantism | 117550 | NSD1 | 606681 | SEQ, MLPA, NGS | S | Syndro | |
Spastic ataxia, autosomal recessive, type 5 | SPAX5 | 614487 | AFG3L2 | 604581 | SEQ, NGS | S | Neuro | |
Spastic Ataxia, Charlevoix-Saguenay type | SACS, spastic ataxia, autosomal recessive type 6, SPAX6, ARSACS | 270550 | SACS | 604490 | SEQ, MLPA, NGS | A | Neuro | |
Spastic paralysis, infantile-onset, ascending | IAHSP | 607225 | ALS2 | KIAA1563 | 606352 | SEQ, NGS | S | Neuro |
Spastic paraplegia type 1, X-linked, | SPG1 | 303350 | L1CAM | 308840 | SEQ, MLPA, NGS | S | Neuro | |
Spastic paraplegia type 10, autosomal dominant, | SPG10 | 604187 | KIF5A | 602821 | SEQ, NGS | S | Neuro | |
Spastic paraplegia type 11, autosomal recessive | SPG11, spastic paraplegia with thin corpus callosum | 604360 | SPG11 | KIAA1840, Spatacsin | 610844 | SEQ, MLPA, NGS | S | Neuro |
Spastic paraplegia type 15, autosomal recessive | SPG15, spastic paraplegia and retinal degeneration, Kjellin syndrome | 270700 | ZFYVE26 | KIAA0321, Spastizin | 612012 | SEQ, NGS | S | Neuro |
Spastic paraplegia type 17, autosomal dominant | SPG17, Silver syndrome | 270685 | BSCL2 | 606158 | SEQ, NGS | S | Neuro | |
Spastic paraplegia type 20, autosomal recessive | SPG20, spastic paraplegia with distal muscle wasting, Troyer syndrome | 275900 | SPG20 | KIAA0610, Spartin | 607111 | SEQ, NGS | S | Neuro |
Spastic paraplegia type 3, autosomal dominant | Strumpell disease | 182600 | ATL1 | SPG3A | 606439 | SEQ, MLPA, NGS | S | Neuro |
Spastic paraplegia type 31, autosomal dominant | SPG31 | 610250 | REEP1 | 609139 | SEQ, MLPA, NGS | S | Neuro | |
Spastic paraplegia type 39, autosomal recessive | SPG39 | 612020 | PNPLA6 | 603197 | SEQ, NGS | S | Neuro | |
Spastic paraplegia type 4, autosomal dominant | SPG4 | 182601 | SPAST | SPG4 | 604277 | SEQ, MLPA, NGS | S | Neuro |
Spastic paraplegia type 5 A, autosomal recessive | SPG5A | 270800 | CYP7B1 | 603711 | SEQ, MLPA, NGS | S | Neuro | |
Spastic paraplegia type 6, autosomal dominant | SPG6 | 600363 | NIPA1 | 608145 | SEQ, MLPA, NGS | S | Neuro | |
Spastic paraplegia type 7, autosomal recessive | SPG7 | 607259 | SPG7 | 602783 | SEQ, MLPA, NGS | S | Neuro | |
Spastic paraplegia type 79, autosomal recessive | SPG79, neurodegeneration with optic atrophy | 615491 | UCHL1 | 191342 | SEQ, MLPA, NGS | S | Neuro | |
Spastic paraplegia type 8, autosomal dominant, | SPG8 | 603563 | WASHC5 | KIAA0196 | 610657 | SEQ, NGS | S | Neuro |
Specific language impairment | SLI | NFXL1 | SEQ, NGS | S | Syndro | |||
Spermatogenic failure type 8 | SPGF8 | 613957 | NR5A1 | 184757 | SEQ, MLPA, NGS | S | Syndro | |
Spherocytosis, type 1 | HS1 | 182900 | ANK1 | 612641 | SEQ, NGS | S | Meta | |
Spinal and bulbar muscular atrophy | SBMA, Kennedy disease | 313200 | AR, CAG repeat in exon 1 | 313700 | REP | S | Neuro | |
Spinal muscular atrophy distal, congenital, nonprogressive | Spinal muscular atrophy, distal, congenital benign, with contractures | 600175 | TRPV4 | 605427 | SEQ, NGS | S | Neuro | |
Spinal muscular atrophy type I | SMA1, Werdnig-Hoffmann disease | 253300 | SMN1 | 600354 | SEQ, MLPA, NGS | S | Neuro | |
Spinal muscular atrophy type II | SMA2 | 253550 | SMN1 | 600354 | SEQ, MLPA, NGS | S | Neuro | |
Spinal muscular atrophy type III | SMA3 | 253400 | SMN1 | 600354 | SEQ, MLPA, NGS | S | Neuro | |
Spinal muscular atrophy type IV, adult form | SMA4 | 271150 | SMN1 | 600354 | SEQ, MLPA, NGS | S | Neuro | |
Spinal muscular atrophy, proximal, late-onset, autosomal dominant | Spinal muscular atrophy Finkel type | 182980 | VAPB | 605704 | SEQ, NGS | S | Neuro | |
Spinal muscular atrophy, type III, modifier of | SMA | 253400 | SMN2 | 601627 | SEQ, MLPA, NGS | S | Neuro | |
Spinocerebellar ataxia type 1 | SCA1 | 164400 | ATXN1 repeat | 601556 | REP | S | Neuro | |
Spinocerebellar ataxia type 11 | SCA11 | 604432 | TTBK2 | 611695 | SEQ, NGS | S | Neuro | |
Spinocerebellar ataxia type 12 | SCA12 | 604326 | PPP2R2B repeat | 604325 | REP | S | Neuro | |
Spinocerebellar ataxia type 15 | SCA15 | 606658 | ITPR1 | 147265 | SEQ, MLPA, NGS | S | Neuro | |
Spinocerebellar ataxia type 17 | SCA17 | 607136 | TBP | 600075 | REP | S | Neuro | |
Spinocerebellar ataxia type 19 | SCA19 | 607346 | KCND3 | 605411 | SEQ, NGS | S | Neuro | |
Spinocerebellar ataxia type 2 | SCA2 | 183090 | ATXN2 repeat | 601517 | REP | S | Neuro | |
Spinocerebellar ataxia type 23 | SCA23 | 610245 | PDYN | 131340 | SEQ, NGS | S | Neuro | |
Spinocerebellar ataxia type 28 | SCA28 | 610246 | AFG3L2 | 604581 | SEQ, NGS | S | Neuro | |
Spinocerebellar ataxia type 29 | SCA29 | 117360 | ITPR1 | 147265 | SEQ, MLPA, NGS | S | Neuro | |
Spinocerebellar ataxia type 3 | SCA3, Machado-Joseph disease | 109150 | ATXN3 repeat | 607047 | REP | S | Neuro | |
Spinocerebellar ataxia type 6 | SCA6 | 183086 | CACNA1A exon 47 CAG repeat | 601011 | REP | S | Neuro | |
Spinocerebellar ataxia type 7 | SCA7 | 164500 | ATXN7 repeat | 607640 | REP | S | Neuro | |
Spinocerebellar ataxia type 8 | SCA8 | 608768 | ATXN8OS repeat | 603680 | REP | S | Neuro | |
Spinocerebellar ataxia with epilepsy | SCAE | 607459 | POLG | POLG1 | 174763 | SEQ, MLPA, NGS | S | Neuro |
Spinocerebellar ataxia, autosomal recessive type 1 | AOA2 | 606002 | SETX | 608465 | SEQ, MLPA, NGS | S | Neuro | |
Split-hand/foot malformation type 4 | SHFM4 | 605289 | TP63 | p63, TP73L | 603273 | SEQ, NGS | S | Syndro |
Spondyloarthropathy, susceptibility to, 1, | SPDA1, Bechterew syndrome | 106300 | HLA-B27 | 142830 | SEQ | S | Meta | |
Spondylocostal dysostosis 2, autosomal recessive | SCDO2 | 608681 | MESP2 | 605195 | SEQ, NGS | S | Tissue | |
Spondylocostal dysostosis-1, autosomal recessive | SCDO1 | 277300 | DLL3 | 602768 | SEQ, NGS | S | Tissue | |
Spondyloepiphyseal dysplasia congenita | SEDC | 183900 | COL2A1 | 120140 | SEQ, MLPA, NGS | S | Tissue | |
Spondyloepiphyseal dysplasia tarda, x-linked | SEDT | 313400 | TRAPPC2 | 300202 | SEQ, NGS | S | Tissue | |
Spondyloepiphyseal dysplasia, maroteaux type | SED, pseudo-Morquio syndrome, type 2 | 184095 | TRPV4 | 605427 | SEQ, NGS | S | Tissue | |
Spondylometaphyseal dysplasia, Kozlowski type | 184252 | TRPV4 | 605427 | SEQ, NGS | S | Tissue | ||
Stargardt disease type 1 | STGD1 | 248200 | ABCA4 | 601691 | SEQ, MLPA, NGS | S | Sensory | |
Stickler syndrome type 2, autosomal dominant | STL2 | 604841 | COL11A1 | 120280 | SEQ, MLPA, NGS | S | Tissue | |
Stickler syndrome type 3, autosomal dominant | STL3 | 184840 | COL11A2 | 120290 | SEQ, NGS | S | Tissue | |
Stickler syndrome type 5, autosomal recessive | STL5 | 614284 | COL9A2 | 120260 | SEQ, NGS | S | Tissue | |
Stickler syndrome type I, autosomal dominant | STL1 | 108300 | COL2A1 | 120140 | SEQ, MLPA, NGS | S | Tissue | |
Subcortical laminar heterotopia | SCLH | 607432 | PAFAH1B1 | LIS1 | 601545 | SEQ, MLPA, NGS | S | Syndro |
Subcortical laminar heterotopia, X-linked | SCLH | 300067 | DCX | 300121 | SEQ, MLPA, NGS | S | Syndro | |
Subtelomeric screening (analysis of all subtelomeric regions by MLPA) | MLPA | S | Micro | |||||
Syndactyly type V | Syndactyly with metacarpal and metatarsal fusion | 186300 | HOXD13 | 142989 | SEQ, MLPA, NGS | S | Tissue | |
Synpolydactyly type I | SPD1, syndactyly type II according to Temtamy and McKusick [PMID: 215242] | 186000 | HOXD13 | 142989 | SEQ, MLPA, NGS | S | Tissue | |
Synpolydactyly with anomalies of the foot | 186000 | HOXD13 | 142989 | SEQ, MLPA, NGS | S | Tissue | ||
Tay-Sachs disease | 272800 | HEXA | 606869 | SEQ, MLPA, NGS | T | Meta | ||
Telangiectasia, hereditary hemorrhagic, type 1 | HHT1, Osler-Rendu-Weber disease type 1 | 187300 | ENG | 131195 | SEQ, MLPA, NGS | T | Tissue | |
Telangiectasia, hereditary hemorrhagic, type 2 | HHT2, Osler-Rendu-Weber disease type 2 | 600376 | ACVRL1 | 601284 | SEQ, MLPA, NGS | T | Tissue | |
Telangiectasia, hereditary hemorrhagic, type 5 | HHT5 | 615506 | GDF2 | 605120 | SEQ, NGS | T | Tissue | |
Temtamy syndrome | TEMTYS | 218340 | C12orf57 | 615140 | SEQ, NGS | T | Syndro | |
Thalassemia, beta | beta hemoglobinopathy | 613985 | HBB | 141900 | SEQ, MLPA, NGS | T | Coagul | |
Thanatophoric dysplasia type I | TD1 | 187600 | FGFR3 | 134934 | SEQ, MLPA, NGS | T | Tissue | |
Thanatophoric dysplasia type II | TD2 | 187601 | FGFR3 | 134934 | SEQ, MLPA, NGS | T | Tissue | |
Thoracic aortic aneurysm type 3 | AAT3, FAA3 | 610168 | TGFBR2 | 190182 | SEQ, MLPA, NGS | T | Tissue | |
Thoracic aortic aneurysm type 4 | AAT4, FAA4 | 132900 | MYH11 | 160745 | SEQ, MLPA, NGS | T | Tissue | |
Thoracic aortic aneurysm type 5 | AAT5 | 609192 | TGFBR1 | 190181 | SEQ, MLPA, NGS | T | Tissue | |
Thoracic aortic aneurysm type 6 | AAT6, FAA6 | 611788 | ACTA2 | 102620 | SEQ, NGS | T | Tissue | |
Thoracic aortic aneurysm type 7 | AAT7 | 613780 | MYLK | 600922 | SEQ, NGS | T | Tissue | |
Thoracic aortic aneurysm type 8 | AAT8 | 615436 | PRKG1 | 176894 | SEQ, NGS | T | Tissue | |
Thoracic aortic aneurysm type 9 | AAT9 | 616166 | MFAP5 | 601103 | SEQ, NGS | T | Tissue | |
Thrombophilia due to antithrombin III deficiency | AT3D | 613118 | SERPINC1 | 107300 | SEQ, MLPA, NGS | T | Coagul | |
Thyroid dyshormonogenesis type 2A | 274500 | TPO | 606765 | SEQ, MLPA, NGS | T | Meta | ||
Thyroid hormone resistance, generalized, autosomal dominant | GRTH | 188570 | THRB | 190160 | SEQ, NGS | T | Meta | |
Thyroid hormone resistance, generalized, autosomal recessive | GRTH, Refetoff syndrome | 274300 | THRB | 190160 | SEQ, NGS | T | Meta | |
Thyroid hormone resistance, selective pituitary | PRTH | 145650 | THRB | 190160 | SEQ, NGS | T | Meta | |
Thyrotoxic periodic paralysis type 1 | TTPP1 | 188580 | CACNA1S | 114208 | SEQ, MLPA, NGS | T | Neuro | |
Thyrotoxic periodic paralysis type 2 | TTPP2 | 613239 | KCNJ18 | 613236 | SEQ, NGS | T | Neuro | |
Tietz albinism-deafness syndrome | 103500 | MITF | 156845 | SEQ, MLPA, NGS | T | Syndro | ||
Timothy syndrome | TS, Long QT syndrome with syndactyly | 601005 | CACNA1C | 114205 | SEQ, NGS | T | Cardio | |
Tooth agenesis, selective, 3 | STHAG3 | 604625 | PAX9 | 167416 | SEQ, NGS | T | Syndro | |
Tooth agenesis-4 with or without ectodermal dysplasia | STHAG4, absence of lateral incisors | 150400 | WNT10A | 606268 | SEQ, MLPA, NGS | T | Syndro | |
Torsion dystonia type 1 | DYT1 | 128100 | TOR1A | 605204 | SEQ, MLPA, NGS | T | Neuro | |
Torsion dystonia type 6 | DYT6 | 602629 | THAP1 | 609520 | SEQ, MLPA, NGS | T | Neuro | |
Townes-Brocks syndrome | TBS | 107480 | SALL1 | 602218 | SEQ, MLPA, NGS | T | Syndro | |
Transcobalamin II deficiency | 275350 | TCN2 | 613441 | SEQ, NGS | T | Meta | ||
Treacher-Collins-Franceschetti syndrome | 154500 | TCOF1 | 606847 | SEQ, MLPA, NGS | T | Syndro | ||
Treacher-Collins-Franceschetti syndrome type 2 | 613717 | POLR1D | 613715 | SEQ, NGS | T | Syndro | ||
Treacher-Collins-Franceschetti syndrome type 3, autosomal recessive | 248390 | POLR1C | 610060 | SEQ, NGS | T | Syndro | ||
Tremor, hereditary essential type 4 | ETM4 | 614782 | FUS | 137070 | SEQ, NGS | T | Neuro | |
Trichorhinophalangeal syndrome, type I | 190350 | TRPS1 | 604386 | SEQ, MLPA, NGS | T | Tissue | ||
Trichorhinophalangeal syndrome, type III | 190351 | TRPS1 | 604386 | SEQ, MLPA, NGS | T | Tissue | ||
Trichothiodystrophy, photosensitive | TTDP | 601675 | ERCC2 | 126340 | SEQ, NGS | T | Geno | |
Tuberous sclerosis 1 | TSC1 | 191100 | TSC1 | 605284 | SEQ, MLPA, NGS | T | Tumor | |
Tuberous sclerosis 2 | TSC2 | 613254 | TSC2 | 191092 | SEQ, MLPA, NGS | T | Tumor | |
UV-sensitive syndrome type 2 | UVSS2 | 614621 | ERCC8 | 609412 | SEQ, NGS | U | Syndro | |
Van der Woude syndrome type 1 | VWS1 | 119300 | IRF6 | 607199 | SEQ, MLPA, NGS | V | Syndro | |
Van der Woude syndrome type 2 | VWS2 | 606713 | GRHL3 | 608317 | SEQ, MLPA, NGS | V | Syndro | |
Vasculopathy, retinal, with cerebral leukoencephalopathy and systemic manifestations | RVCLS, cerebroretinal vasculopathy, hereditary, CRV | 192315 | TREX1 | 606609 | SEQ, MLPA, NGS | V | Syndro | |
Velocardiofacial syndrome | 192430 | del22q11.2 | MLPA | V | Micro | |||
Vitelliform macular dystrophy, type 3 | VMD3 | 608161 | PRPH2 | 179605 | SEQ, MLPA, NGS | V | Sensory | |
Vitreoretinochoroidopathy | VRCP | 193220 | BEST1 | 607854 | SEQ, MLPA, NGS | V | Sensory | |
Von Hippel-Lindau syndrome | VHL | 193300 | VHL | 608537 | SEQ, MLPA, NGS | V | Kidney | |
Von Hippel-Lindau syndrome | VHL | 193300 | VHL | 608537 | SEQ, MLPA, NGS | V | Tumor | |
Waardenburg syndrome type 1 | WS1 | 193500 | PAX3 | 606597 | SEQ, MLPA, NGS | W | Syndro | |
Waardenburg syndrome type 2A | WS2A | 193510 | MITF | 156845 | SEQ, MLPA, NGS | W | Syndro | |
Waardenburg syndrome type 2E | WS2E | 611584 | SOX10 | 602229 | SEQ, MLPA, NGS | W | Syndro | |
Waardenburg syndrome, type 2D | WS2D | 608890 | SNAI2 | 602150 | SEQ, MLPA, NGS | W | Syndro | |
Waardenburg syndrome, type 3 | WS3, Klein-Waardenburg-Syndrom | 148820 | PAX3 | 606597 | SEQ, MLPA, NGS | W | Syndro | |
Waardenburg syndrome, type 4A | WS4A | 277580 | EDNRB | 131244 | SEQ, MLPA, NGS | W | Syndro | |
Waardenburg syndrome, type 4B | WS4B | 613265 | EDN3 | 131242 | SEQ, MLPA, NGS | W | Syndro | |
Waardenburg syndrome, type 4C | WS4C | 613266 | SOX10 | 602229 | SEQ, MLPA, NGS | W | Syndro | |
Waardenburg-Shah syndrome, PCWH syndrome | 609136 | SOX10 | 602229 | SEQ, MLPA, NGS | W | Syndro | ||
Weaver syndrome | Weaver-Smith syndrome | 277590 | EZH2 | 601573 | SEQ, NGS | W | Syndro | |
Werner syndrome | 277700 | WRN | RECQL2 | 604611 | SEQ, NGS | W | Syndro | |
Werner syndrome, atypical | LMNA | 150330 | SEQ, MLPA, NGS | W | Syndro | |||
Williams-Beuren syndrome | 194050 | del7q11.23 | MLPA | W | Micro | |||
Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome | WAGR syndrome, chromosome 11p13 deletion syndrome | 194072 | del11p13 (PAX6, WT1 genes) | 607108, 607102 | MLPA | W | Micro | |
Wilson disease | 277900 | ATP7B | 606882 | SEQ, MLPA, NGS | W | Meta | ||
Witkop syndrome | Nail dysplasia with hypodontia | 189500 | MSX1 | 142983 | SEQ, NGS | W | Syndro | |
Xeroderma pigmentosum, group D | XPG | 278730 | ERCC2 | 126340 | SEQ, NGS | X | Geno | |
Xeroderma pigmentosum, group G | XPG | 278780 | ERCC5 | 133530 | SEQ, NGS | X | Geno | |
X-linked mental retardation with dystonia, ataxia and seizures | Partington syndrome | 309510 | ARX | 300382 | SEQ, MLPA, NGS | X | Epi | |
X-linked reducing body myopathy-1 with infantile or early childhood onset | RBMX1A | 300717 | FHL1 | 300163 | SEQ, NGS | X | Neuro | |
X-linked reducing body myopathy-1 with late childhood or adult onset | RBMX1B | 300718 | FHL1 | 300163 | SEQ, NGS | X | Neuro | |
2q32-q33-Microdeletion syndrome | Glass syndrome | 612313 | SATB2 | 608148 | MLPA | 2 | Micro | |
3-hydroxyacyl-CoA dehydrogenase deficiency | HADH Deficiency | 231530 | HADH | 601609 | SEQ, NGS | 3 | Meta | |
46XY sex reversal type 1 | SRXY1, gonadal dysgenesis, true hermaphroditism | 400044 | SRY | 480000 | SEQ, MLPA, NGS | 4 | Syndro | |
46XY sex reversal type 3 | SRXY3, gonadal dysgenesis | 612965 | NR5A1 | 184757 | SEQ, MLPA, NGS | 4 | Syndro | |
5-fluorouracil toxicity | 274270 | DPYD, exons 11, 13, 14 and 22 | 612779 | SEQ | 5 | Pharma |